IMPROVING SEXUAL FUNCTION IN PATIENTS WITH ENDOMETRIOSIS VIA PELVIC PHYSICAL THERAPY.
L. J. Wurn, B. F. Wurn, C. R. King III, A. S. Roscow, E. S. Scharf, J. J. Shuster. Clear Passage Therapies, Inc., Gainesville, FL; Florida Medical Research Institute; Southeastern Women’s Health, Gainesville, FL; None, n/a, FL; Dept of Epidemiology and Public Health Policy, Coll of Medicine, Univ of Florida, Gainesville, FL.
OBJECTIVE: Among the most common symptoms experienced by the 5 million American women with endometriosis is pain during sexual intercourse. The purpose of this study was to assess the efficacy of a non-invasive manual pelvic physical therapy in reducing dyspareunia and improving overall sexual function in this population.
DESIGN: Retrospective analysis.
MATERIALS AND METHODS: A retrospective analysis was performed on 14 patients (mean age = 33.8) with endometriosis, confirmed by laparoscopy or laparotomy. The outcome measure was post-treatment test scores vs. pre-treatment test scores on the validated Female Sexual Function Index (FSFI) full scale and 6 individual domains (desire, arousal, lubrication, orgasm, satisfaction, and pain). After completing the pre-test, the 14 patients underwent 20 hours of manual pelvic physical therapy designed to address restricted soft tissue mobility due to micro-adhesions and adhesions. The post-test was completed 6 weeks after the last treatment date to allow time for the body to assimilate the changes and undergo a full menstrual cycle. RESULTS: Although the FSFI was designed to evaluate the relative degree of dysfunction within the individual domains, there is obvious overlap among the 6 categories. The Wilcoxon Signed-Rank Test (2-sided) was used on the paired post-test/pre-test differences. It showed a statistically significant improvement (P = <0.00 I) on the overall full scale score, as well as on each of the 6 individual domains: Desire (p = 0.011 ); Arousal (p = 0.004); Lubrication (p = 0.00 I); Orgasm (p = 0.004); Satisfaction (p = 0.005); and Pain (p <0.00 I).
CONCLUSION: Many aspects of sexual dysfunction in patients with endometriosis appear to be treatable by a non-pharmaceutical, non-surgical pelvic physical therapy technique. The therapy should be considered as a new adjuvant to existing medical and gynecologic treatments.
TREATING ENDOMETRIOSIS PAIN WITH A MANUAL PELVIC PHYSICAL THERAPY.
L. J. Wurn, B. F. Wurn, C.R. King III, A. S. Roscow, E. S. Scharf, J. J. Shuster. Clear Passage Therapies, Inc., Gainesville, FL; Florida Medical Research Institute; Southeastern Women’s Health, Gainesville, FL; Dept. of Epidemiology and Public Health Policy. Coll. of Medicine, Univ. of Florida, Gainesville, FL.
OBJECTIVE: Approximately 5 million American women (mainly ages 25-40) suffer from endometriosis, a chronic and often exceedingly painful disease. Although not necessarily progressive, endometriosis pain usually increases during menstruation and sexual intercourse. Since this pelvic physical therapy has already been shown to reduce dyspareunia, the purpose of this study was to assess its efficacy in treating endometriosis pain.
RESULTS: The Wilcoxon Signed-rank Test (2-sided) was used on the paired pre-test/post-test differences. The Total Difference, comprising pain during 3 phases of the menstrual cycle (ovulation, pre-menstruation, and menstruation), was significant (P = 0.014), with the lessening of pain during menstruation accounting for much of the difference (P = 0.008). The paired pre-test/post-test difference in pain during sexual intercourse was also significant (P = 0.001).
CONCLUSION: This manual pelvic physical therapy offers a non-surgical, non-pharmaceutical alternative to treating pain due to endometriosis. Moreover. It appears to have its greatest effect on the typically most painful times (i.e., menstruation and sexual intercourse).
TREATING HYDROSALPINX WITH A MANUAL PHYSICAL THERAPY.L. J. Wum, B. F. Wum, M. Kan, C.R. King III, A. S. Roscow, E. S. Scharf. Clear Passage Therapies, Inc., Gainesville, FL; Newport Fertility Center, Newport Beach, CA; Florida Medical Research Institute; and Southeastern Women’s Health, Gainesville, FL.
OBJECTIVE: Hydrosalpinx of the fallopian tube is largely regarded as an indicator of tubal dysfunction causing infertility. Several studies have documented the detrimental effects of hydrosalpinges on IVF pregnancy rates. Surgical removal of hydrosalpinges is generally recommended because it is associated with improvement in IVF pregnancy rates. The purpose of this study is to examine the efficacy of a non-invasive manual pelvic physical therapy to improve the function of fallopian tubes that have been compromised by hydrosalpinx.
DESIGN: Retrospective analysis.
MATERIALS AND METHODS: A retrospective analysis was performed on eight patients with documented tubal occlusion who met the additional inclusion criterion of hydrosalpinx in one or both tubes, diagnosed by hysterosalpingogram or laparoscopic chromotubation. These patients underwent manual physical therapy in order to treat the hydrosalpinges and improve fertility. The therapists were able to indirectly access the fallopian tubes by manipulating the peritoneum, uterine and ovarian ligaments, and adjacent structures. Post-treatment unilateral or bilateral tubal patency in the tube(s) with hydrosalpinx was confirmed by hysterosalpingogram. The mean interval between the last treatment date and patency confirmation was 5 weeks. A second outcome measure was a natural and/or IVF pregnancy within the 2-year follow-up period, without surgical intervention to address the hydrosalpinx.
RESULTS: Of this subset of patients with total occlusion plus hydrosalpinx (mean age = 35), 4/8 (50%) demonstrated post-treatment patency in one or both of the tubes containing the hydrosalpinx. Of the 4 patent patients, 2/4 (50%) reported natural post-therapy full-term pregnancies via the tube with hydrosalpinx as follows: one had a successful post-treatment IVF pregnancy and delivery, followed by a natural intrauterine pregnancy/delivery; a second patient had a natural pregnancy/delivery and a second subsequent pregnancy. Of the 4 non-patent patients, one had a laparoscopy to remove the tubes, became pregnant through IVF but miscarried; another had a natural ectopic pregnancy after therapy; a third had a successful IVF pregnancy and live birth delivery; the fourth reported no pregnancy after therapy.
CONCLUSION: The presence of hydrosalpinges is associated with infertility and decreased pregnancy rates with IVF. Surgical removal of hydrosalpinges is often recommended. This physical therapy offers a non-surgical option to treat infertility in patients with hydrosalpinges and tubal occlusion.
Supported by:
The Official Journal of the American Society for Reproductive Medicine
Decreasing pain and improving function and quality of life are important topics for patients who refuse, or are not candidates for, traditional medical interventions, and those at the end stages of disease. Patients with inoperable, metastatic bowel carcinoma who experience pain and small bowel obstruction (SBO) as a result of adhesions are a subset of these patients. The standard treatment, adhesion and/or resection surgery, followed by post-surgical medications to prevent infection and decrease pain, may not be ideal in end-stage cancer patients. We treated such a patient using manual soft tissue physical therapy with goals of decreasing her pain and alleviating symptoms of bowel obstruction secondary to adhesions successfully, using a protocol we developed initially to open fallopian tubes that were blocked by adhesions.
The patient was a 61-year-old married woman with a history of multiple abdominopelvic surgeries over the last 12 years, including hysterectomy, ileostomy, and ileostomy reversal with chemotherapy and radiation for treatment of stage IIIB ovarian/peritoneal carcinoma. She experienced SBO episodes every 2-3 months and had five adhesiolysis and/or resection surgeries to attempt to repair the bowel. Because she had undergone a recent exploratory laparoscopy that revealed metastasis to the omentum, her physicians were reluctant to perform any further surgeries, and the patient requested no more surgical interventions.
She was unable to eat or drink, so a peripherally inserted central catheter (PICC line) was placed, and she received total parenteral nutrition (TPN) daily. She experienced chronic pain associated with the SBOs at a level of 4-5/10 that increased throughout the day with movement. The patient was undergoing chemotherapy and medicated with Nexium 40mg qd, Compazine 10mg prn, Zofran 4mg prn, Ativan 1mg qd, multivitamin bid, Vitamin D 2000mg qd, Co-Enzyme Q10 qd, and Dilaudid prn for pain. Her goals were to relieve the abdominal pain, decrease SBO incidents, eat a normal diet, and travel.
The patient underwent 29 hours of manual soft tissue physical therapy, 1–6 times over six months, focused on detaching the abdominal adhesions, and was instructed in self-treatment techniques. At initial evaluation, she said she must reside near a hospital, due to the PICC line and recurring SBOs.
She demonstrated improvement through the duration of therapy with significant pain decrease and functional increase. By discharge, her physician had removed the PICC lines because she had returned to eating a normal diet (including hamburger). She was then able to travel overseas with her husband, a significant increase in her quality of life.
Alleviating pain and dysfunction, and improving life quality are challenging goals in patients with inoperable gastrointestinal cancer. Here we report a successful nonsurgical treatment for abdominal adhesions, pain, and dysfunction in a terminally ill patient. Before therapy, she lived with recurring SBOs, repeated surgeries, pain, and dysfunction. Her only nutrition was intravenous TPN. After undergoing this manual soft tissue physical therapy, she was able to eat a normal diet and participate in activities she desired.
References
AlternativeMedicineandRehabilitation.Wainapel SF, Fast A (eds). Demos Medical Publishing, 2003. Available from: http://www.ncbi.nlm.nih.gov/books/NBK11183/ (Last accessed September 4, 2012.)
Principlesofmanualmedicine, 2e. Greenman PE. Williams & Wilkins, Baltimore, Maryland, 1996.
Brown JS. Rehabilitation of Soft Tissue Injuries in the 1990s. Dynamic Chiropr 1991;9(21):1–3.
Wurn BF, Wurn LJ, King CR, Heuer M a, Roscow AS, Hornberger K, et al: Treating fallopian tube occlusion with manual pelvic physical therapy. Altern Ther Health Med 2008;14(1):18–23.
Wurn BF, Wurn LJ, King CR, Heuer MA, Roscow AS, Scharf ES, et al: Treating female infertility and improving IVF pregnancy rates with a manual physical therapy technique. MedGenMed 2004;6(2):51.
Wurn BF, Wurn LJ, Patterson K, King CR, Scharf ES: Decreasing dyspareunia and dysmenorrhea in women with endometriosis via a manual physical therapy: Results from two independent studies. J Endometriosis 2011;3(4):188–96.
Amanda D Rice, Kimberley Patterson, Evette D Reed, Belinda F Wurn, Kristen Robles, Bernhard Klingenberg, Leonard B Weinstock, Janey SA Pratt, C Richard King III, Lawrence J Wurn
Amanda D Rice, Department of Internal Medicine, College of Medicine-Phoenix, University of Arizona, Phoenix, AZ 85004, United States
Kimberley Patterson, Evette D Reed, Belinda F Wurn, Kristen Robles, Lawrence J Wurn, Clear Passage Therapies, Gainesville, FL 32606, United States
Bernhard Klingenberg, Department of Mathematics and Statistics, Williams College, Williamstown, MA 01267, United States
Leonard B Weinstock, Clinical Medicine and Surgery, Washington University School of Medicine, Specialists in Gastroenterology, LLC, St. Louis, MO 63141, United States
Janey SA Pratt, Department of Surgery, Stanford University School of Medicine, Palo Alto, CA 94035, United States
C Richard King III, College of Medicine, University of Florida, Gainesville, FL 32607, United States
ORCID number: Amanda D Rice (0000-0003-0708-2160); Kimberley Patterson (0000-0003-3370-9924); Evette D Reed (0000-0003-2298-6993); Belinda F Wurn (0000-0002-0413-4685); Kristen Robles (0000-0002-3428-0544); Bernhard Klingenberg (0000-0001-9959-9989); Leonard B Weinstock (0000-0001-6484-1691); Janey SA Pratt (0000-0002 -6850-3427); C Richard King III (0000-0003-0807-1260); Lawrence J Wurn (0000-0002 -1393-1264).
Author contributions: Rice AD, Klingenberg B, King CR and Wurn LJ designed the study; Patterson K, Reed ED, Wurn BF and Wurn LJ performed the treatment; Rice AD performed subject follow-up and control subject data collection; Klingenberg B performed the statistical analysis; Rice AD wrote the manuscript; Patterson K, Reed ED, Wurn BF, Robles K, Klingenberg B, Weinstock LB, Pratt JS, King CR and Wurn LJ revised the manuscript for final submission.
Institutional review board statement: This study was approved by the MaGil Institutional Review Board.
Informed consent statement: All subjects provided consent for the study. Treated subjects provided written consent; untreated subjects provided consent via the Assessment Center online system.
Conflict-of-interest statement: Belinda F Wurn and Lawrence J Wurn are the owners of Clear Passage. All other authors report no conflicts.
Data sharing statement: Data will be available upon request, de-identified with IRB approval.
CONSORT 2010 statement: The guidelines of the CONSORT 2010 Statement have been adopted for this study.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Manuscript source: Unsolicited manuscript
Correspondence to: Lawrence J Wurn, Research Associate, Clear Passage Therapies, 4421 NW 39th Ave, Suite 2-2, Gainesville, FL 32606, United States. Telephone: +1-352-3361433
Fax: +1-352-3369980
Received: February 26, 2018
Peer review started: February 27, 2018
First decision: March 15, 2018
Revised: April 22, 2018
Accepted: May 6, 2018
Article in press: May 6, 2018
Published online: May 21, 2018
Abstract
AIM
To compare (1) the quality of life and (2) the rate of recurrent small bowel obstructions (SBO) for patients treated with novel manual physiotherapy vs no treatment.
METHODS
One hundred and three subjects (age 19-89) with a history of recurrent adhesive SBO were treated with a manual physiotherapy called the Clear Passage Approach (CPA), which focused on decreasing adhesive crosslinking in abdominopelvic viscera. Pre- and post-therapy data measured recurring obstructions and quality of life, using a validated test sent 90 days after therapy. Results were compared to 136 untreated control subjects who underwent the same measurements for subjects who did not receive any therapy, which is the normal course for patients with recurring SBO. Comparison of the groups allowed us to assess changes when the physiotherapy was added as an adjunct treatment for patients with recurring SBO.
RESULTS
Despite histories of more prior hospitalizations, obstructions, surgeries, and years impacted by bowel issues, the 103 CPA-treated subjects reported a significantly lower rate of repeat SBO than 136 untreated controls (total obstructions P = 0.0003; partial obstructions P = 0.0076). Subjects treated with the therapy demonstrated significant improvements in five of six total domains in the validated Small Bowel Obstruction Questionnaire (SBO-Q). Domains of diet, pain, gastrointestinal symptoms, quality of life (QOL), and pain severity when compared to post CPA treatment were significantly improved (P < 0.0001). The medication domain did not change in the CPA treated group (P = 0.176).
CONCLUSION
CPA physical therapy was effective for patients with adhesive SBO, with significantly lower recurrence rate, improvement in reported symptoms, and overall quality of life of subjects.
Key words: Clear passage approach; Manual therapy; Physical therapy; Small bowel obstructions; Adhesions; Physiotherapy; Alternative therapy
Rice AD, Patterson K, Reed ED, Wurn BF, Robles K, Klingenberg B, Weinstock LB, Pratt JS, King CR, Wurn LJ. Decreasing recurrent bowel obstructions, improving quality of life with physiotherapy: Controlled study. WorldJGastroenterol 2018; 24(19): 2108-2119 Available from: URL: http://www.wjgnet.com/1007-9327/full/v24/i19/2108.htm DOI: http://dx.doi.org/10.3748/wjg.v24.i19.2108
INTRODUCTION
Adhesive small bowel obstruction (SBO) is a common life-threatening complication of surgery or abdominal trauma in both pediatric and adult populations, typically caused by adhesions that form as a normal part of the healing process[1-3]. As a side effect of the inflammatory response required for healing to occur, adhesions form in tissues at and near the surgical repair within hours, due to the presence of collagen and scar tissue mediators.
Surgery is frequently cited as the primary cause of adhesive bowel obstruction; repeat surgery increases the risk of adhesion formation[4]. The financial cost per patient for adhesiolysis and bowel resection was $65955 and $114175, respectively, with 30-day hospital readmission rates of 12.3% and 18.1% in the United States in 2010[5]. The average hospital stay for cases of SBO surgery was 14.2 days, and for abdominal adhesiolysis was 8.4 days [5].
The present cost of a one-week course of CPA physical therapy is under $7000 in the United States (and is comparable in the United Kingdom). The therapy is performed in an outpatient setting; no hospitalization or surgery is required.
A large previously published clinical study that followed adult subjects 10 years post-surgery found that more than 30% of the surgical small bowel resection subjects underwent additional surgery due to adhesions within the study time frame[6]. In a prospective analysis of patients undergoing laparotomy who had previously had one or more abdominal operations, 93% (195/210) were found to have adhesions attributable to their prior surgery[1]. Patients with mesh inserted during surgery have been identified as having increased adhesion formation, leading to increased complexity of future surgical procedures[7-9].
Thus, adhesion-related disease causes significant surgical efforts and hospital resources and comprises major expenditures each year. Additionally, there is a considerable negative impact on the patients’ quality of life (QOL).
In the absence of bowel ischemia, strangulation, or perforation, current guidelines for the management of SBO are gastric decompression with suction, full-strength gastrographin (in some institutions), and IV hydration for the first 24-72 h to see if the obstruction will resolve without surgery[10]. While sometimes effective in treating the current obstruction, this approach does not address the internal adhesions or the risk of subsequent bowel obstructions[11,12]. The only treatment currently available to reverse adhesive bowel obstructions is surgery, which frequently causes new adhesions. A number of surgical techniques, modifications, and adhesion-preventing medications and barriers have been investigated, but no solution has been shown to significantly prevent the formation of adhesions to date[13-19]. Thus, any therapy that decreases the risk of bowel obstruction in the absence of surgery is of significant importance.
Manual physical therapy (mPT), a method of physiotherapy and rehabilitation, is used to treat patients with a wide variety of adhesive conditions, including burns, adhesive capsulitis, radiculopathy, pain, infertility, and lessening of scars[20-30]. This therapy has shown promise in preventing adhesion formation in animal models[31,32]. The Clear Passage Approach (CPA), a specialized mPT regimen hypothesized to deform the adhesions that cause SBO episodes, has been demonstrated as effective in decreasing adhesions, pain, and improving QOL in subjects with recurrent SBO in case-control and efficacy studies[33-35]. In pilot studies, independent radiologic reports showed that the therapy cleared bowel stricture and obstruction, obviating the need for planned laparotomy for adhesiolysis and SBO[36,33-35].
Surgery is often necessary in cases of bowel obstruction complicated by ischemia or caused by hernia or cancer, surgery has not been shown to improve quality of life (QOL), reduce pain, or reduce recurrence rate in patients with adhesive SBO. Further, except as shown in pilot studies of CPA therapy, there is currently no other treatment available to patients with known adhesions who are not obstructed to reduce recurrence, pain, or need for further surgery. In this study, we report on the use of the CPA, a manual physical therapy protocol, to treat abdominal and pelvic adhesions that cause SBO, and to improve the quality of life (QOL) of study subjects when compared to untreated subjects in a control arm.
Aim and hypothesis
The aim of the study is twofold: (1) to determine whether manual physiotherapy can lower the rate of repeat SBO in patients who have undergone prior adhesive bowel obstructions and surgeries, and (2) to examine whether the therapy can improve the quality of life of these patients, using a validated test.
The hypothesis is that the manual physiotherapy treatment can decrease SBO recurrence and improve the self-reported quality of life in subjects with a history of adhesive SBO, compared to untreated control subjects.
MATERIALS AND METHODS
Eligibility criteria
Subjects in the retrospective CPA treatment arm were selected for inclusion in the study based on medical history and completion of both a pre-treatment and post-treatment questionnaire. Only adult subjects were included in this study. Exclusion criteria included: BMI > 36, active infection, abnormal ovarian cysts, surgery within the last 90 days, and bleeding disorders. Each subject was provided with written informed consent, as is standard for clinical practice. Subjects with a recent history of cancer were excluded from this study. A total of 103 subjects were treated at one of five private physical therapy clinics affiliated with Clear Passage between November 2012 and October 2015. All CPA therapists and affiliates completed an 80-hour practical training and evaluation course prior to becoming certified in the Clear Passage Approach. All subjects with follow-up were eligible and included in the analysis.
Subjects in the control arm were recruited via a website and online advertisements for the study. Inclusion criteria included: adult subjects who had experienced a partial or total bowel obstruction within the last two years. Exclusion criteria included: Cancer within the last 5 years, chemotherapy or radiation treatments in the last 10 years, current pregnancy, or prior treatment at Clear Passage. All study-related activities were performed via the NIH Assessment Center (www.assessmentcenter.net), including screening, informed consent, and all data collection. A total of 460 subjects were screened, with 281 subjects eligible and 260 completing the initial questionnaire; 6 subjects were removed from the control study due to having previously received CPA treatment, 117 subjects were lost to follow-up, and 1 subject was removed due to less than 50% of the follow-up questionnaire being completed. A total of 136 subjects completed both questionnaires and were included in the analysis. The study diagram is shown in Figure 1. This study was approved by the MaGil Institutional Review Board.
Study design
This was a non-randomized controlled study comparing subjects with a history of SBO who underwent CPA treatment to untreated control subjects. The CPA treatment group included a retrospective chart review of subjects treated for adhesive disease with a history of SBO who had undergone standard clinic follow-up. All subjects included in the treatment arm received treatment within private outpatient physical therapy clinics by therapists certified in the CPA. Subjects in a prospective untreated control arm, including those not treated with the CPA, were recruited for participation in a survey-based observational data collection.
Outcomes were measured in an observational manner using the validated paper-based SBO Questionnaire (SBO-Q) using previously established quartiles[37]. The SBO-Q was developed and validated to be used as a patient-reported tool to quantify the experiences of patients with recurrent SBOs. The questionnaire comprises five domains and a pain rating section. Each domain measures a distinct aspect of QOL. The Diet domain assesses the diet of the subject, from inability to tolerate any liquid to a normal solid food diet. The Pain domain reports pain throughout the body, with oral intake of food or liquid, and with bowel function.
Figure 1: Study diagram.
The Gastrointestinal (GI) Symptom domain quantifies symptoms often associated with SBO, such as nausea, emesis, bowel spasm, and constipation. The Medication domain reports the frequency of medications required to maintain bowel function. The QOL domain quantifies the amount of time off work, social activities, and overall concern of the patient regarding their bowel function. These tend to be major lifetime concerns for many people who experience recurring bowel obstructions.
Subjects provided previous medical history and records; no radiologic evaluations were performed as part of the study. Questionnaires were completed prior to treatment for the control measure. The post-treatment questionnaires were sent to the subjects 90 days post-treatment, with completion at 78-140 days post-treatment for the CPA treatment arm and 90-115 days for the control arm subjects.
Sample size calculation
For evaluating the power of our study, we made some simplifying assumptions. We assumed that differences in the 6 domain scores before and after treatment follow a normal distribution. For all but two of the SBO-Q domains, we assumed that the mean difference was zero (i.e., no treatment effect), but for two domains, we assumed that the treatment lowered the average domain score by 1 point. We assumed that the standard deviation of each difference was 2.5 points. We then simulated the power by looking at the proportion of times that both multiplicities adjusted two-sided P-values for the two domains where we assumed a treatment effect was less than 5%. When selecting a sample size of 100, this was the case in 82% of our simulations. Therefore, 100 patients in the pre- and post-treatment comparison result in at least 80% power to detect a significant difference of 1 point in the mean domain score of two domains. All computations were made in the statistical software R[38].
Treatment
Subjects treated with the CPA received manual therapy to areas of the body identified by the treating therapists as showing decreased mobility or function during the evaluation via palpation and range of motion tests. All subjects were evaluated from head to toe. In the case of these subjects, the focus of the therapy was on the abdominopelvic viscera that demonstrated decreased mobility, hypothesized to be due to adhesions formed after surgery, trauma, or other tissue damage, therefore leading to SBO episodes. The majority of the therapy focused on treating abdominopelvic viscera that demonstrated decreased mobility with palpation. Treatment was administered in multiple-hour sessions, which included up to four hours a day over the course of 5 days, with the typical subject completing 20 h of treatment. The average number of treatment hours per subject was 22.6 ± 8.5 h with a range of 10-74 h; 75 of 103 subjects in the CPA treatment group received 20 h of treatment.
In order to decrease adhesions, the CPA uses techniques from a variety of manual modalities to treat the subject in an individualized manner, focusing on each subject’s areas of restriction and concern with the goal of deforming adhesions and increasing the mobility of adhered tissues and organs, working from the most superficial tissues to those deeper in the body. The therapy accomplishes this by the use of various site-specific pressures across restrictive bands of adhered tissues and structures within the abdomen and pelvis, using a bimanual deep massage. The intent of the therapy is to detach and reverse the cross-linking.
Characteristics
Control
CPA treatment
Pvalue
Age, yr
Median
33.5
57
< 0.001
Range
19-71
19-89
Sex
Male
58
33
0.0853
Female
78
70
Race
White
80
90
Black/African American
39
1
American Indian/Alaska Native
1
2
Asian
3
2
Native Hawaiian/Pacific Islander
0
0
Other
11
0
Unknown
2
8
Ethnicity
Hispanic or Latino
12
1
Not Hispanic or Latino
108
91
Unknown
16
11
Marital Status
Married/long term relationship
47
69
Single
63
16
Divorced/widowed
25
11
Unknown
1
7
CPA: Clear Passage Approach.
Binds collagenous fibers together to form adhesions. The therapists work progressively deeper from the most superficial tissues, restoring mobility via myofascial release[39]. Adhesions within and between organs and interstitial spaces within the viscera were addressed using the Wurn technique[29,34], which is a bimanual soft tissue manipulation that can include a slow stretch to adhered areas within the abdomen and pelvis, previously shown to return patency to occluded fallopian tubes. The intent of this technique is to detach crosslinks that bind collagen fibers, thus shearing apart adhesions manually, in order to return the tissues to a more mobile, less adhered state. Toward the end of deep tissue work, CPA certified therapists may use visceral manipulation to increase organ motility[39]. The amount of force and time the force was applied to each area has the potential to be significant, but was maintained within the tolerance of the subject in accordance with the guidelines of the American Physical Therapy Association. Detailed clinical treatment records were maintained throughout the course of therapy.
Subject monitoring
Subjects enrolled in the control arm of the study were not monitored, as this was an observational web-based study arm. Subjects included in the treatment arm were monitored daily for changes in pain, diet, bowel habits, and overall well-being during their treatment, as is standard practice. Adverse events were monitored by the treating therapists during the course of treatment and reviewed during the chart review process. There were no adverse events reported in the CPA treated group within the clinical data or by follow-up.
Disease scoring
The overall degree of adhesive disease was determined using a clinic-generated disease scoring table that takes into account all qualitative and quantitative measures performed during the initial evaluation and post-treatment discharge assessment. The degree of impact on a subject’s quality of life for range of motion was determined using multiple resources, as well as the extensive experience of the therapists. Multiple other standard physiotherapy tests were also performed and included in the assessment for disease score[40-44]. Supplemental Table 1 contains the disease scoring protocol in which the score is expressed as a decimal, with 0 representing no disease or impact on overall function, and 1 is severely impacted.
Statistical analysis
We used χ2 tests and t-tests for the analysis comparing the demographic and medical variables between the treated and control groups.
For analyzing the multivariate responses from the SBO-Q, we used the minimum P-value based on a paired t-statistic for each survey question as the test statistic for the overall and the domain hypotheses[45]. The raw and multiplicity-adjusted P-values displayed in tables refer to testing the null hypothesis that the mean difference between the initial and follow-up surveys equals 0. Since there are 6 domains for which we tested for a mean difference, we used multiplicity-adjusted P-values to adjust the raw P-values and account for the fact that we are testing 6 hypotheses simultaneously. For a particular domain, a significant difference in the mean domain score can be concluded when the corresponding multiplicity-adjusted domain P-value is less than 0.05.
Control
CPA treatment
Pvalue
Number of previous surgeries
0
4
4
< 0.001
1-2
89
16
3-5
39
34
> 6
3
49
unknown
1
0
Number of prior partial bowel obstructions in the last 3 yr
< 0.001
0
3
24
1-10
132
70
11-20
1
8
> 20
0
1
Number of prior total bowel obstructions
0.4894
0
4
53
1
47
29
2
46
11
3
27
3
4 or more
12
7
The number of years of impact on life due to bowel issues
Average (SD)
5.5 (7.2)
10.7 (11.2)
< 0.0001
CPA: Clear Passage Approach.
Using the multiplicity-adjusted P-values (computed via the Bonferroni correction) will control the overall (familywise) error rate at 5%. Similarly, the multiplicity-adjusted P-values for each survey question account for the fact that we are testing 37 hypotheses comparing mean differences simultaneously, one for each question. For any given survey question, a multiplicity-adjusted P-value less than 0.05 implies a significant difference in the mean score, controlling the overall rate of Type I errors at 5% when testing these 37 hypotheses simultaneously.
The statistical package R (R Foundation for Statistical Computing, Vienna, Austria) was used for all statistical analyses.
RESULTS
impacted their lives was 5.5 ± 7.2 for the control group and 10.7 ± 11.2 for the CPA treated group (P<0.001).
Rates of recurrent SBO
All subjects at the 90-day follow-up questionnaire were queried regarding the number of bowel obstructions, hospitalizations, and surgeries for SBO experienced. There were differences between the groups, with the CPA treated group reporting fewer total number of obstructions, hospitalizations, and surgeries. A total of 124 control and 103 CPA treated subjects responded to the questions. 21.77% of the control group subjects and 8.74% of the CPA group subjects experienced a partial bowel obstruction between the two questionnaires (P=0.0076), 14.52% of control group subjects and 0.97%.
The CPA group subjects reported a total bowel obstruction.
A total of 103 CPA treated subjects and 136 untreated control subjects were included in the analysis. Demographics for study subjects are located in Table 1, and the number of prior surgeries and bowel obstructions is located in Table 2. Subjects in the CPA treatment group were significantly older, and the total number of prior surgeries, partial SBOs, and years impacted with bowel symptoms was much higher than that of the control group. There were 46.2% male subjects in the control group and 32% male subjects in the CPA treated group (P = 0.0853). The average age of subjects in the control group was 36.4 ± 12.5 years and 54.5 ± 15.7 years for the CPA treated group (P<0.001); the average number of prior surgeries in the control group was 2.07 ± 1.29 as compared to 4.56 ± 2.86 for the CPA treated (P=0.0001). The average number of prior partial SBOs in the control group was 1.88 ± 1.60 and 3.97 ± 5.09 in the CPA treated group (P=0.0001). The total number of SBO was 2.17 ± 1.85 for the control group and 1.68 ± 7.95 for the CPA treated group (P=0.4894). The number of years the subjects reported bowel symptoms (P=0.0003): 5.65% of control group subjects, and 1.94% of CPA group subjects reported undergoing surgery for a bowel obstruction (P = 0.1548). The differences between untreated and treated patients at follow-up would naturally extrapolate into a sizable decrease in cost, due to avoiding repeat SBO-related hospitalizations and surgeries.
SBO-Qanalysis
For both the control and CPA group, we tested the null hypothesis that for each of the 6 domains, the mean domain score the first time the survey was administered was equal to the mean domain score the second time the survey was administered 90 days later. The alternative hypothesis was that there was a significant difference in the mean domain score between the initial and follow-up administration of the survey for at least one domain. Missing data from any question/subject were removed from the overall analysis.
For the control group data, despite the fact that no intervention took place between the two times the survey was conducted
Domain question
Difference mean, St.Dev
RawP–value
Multiplicity-adjusted P-value
Lower confidence bound
Upper confidence bound
Diet
-0.06
0.93
0.425
1.000
-0.28
0.15
Liquid
-0.09
1.08
0.342
1.000
-0.39
0.21
Soft
-0.20
1.20
0.055
1.000
-0.54
0.14
Solid
-0.11
1.48
0.388
1.000
-0.53
0.31
Anything
0.13
1.35
0.256
1.000
-0.25
0.51
Pain1
0.17
0.61
0.002
0.013
0.02
0.31
General2
0.50
1.23
0.000
0.000
0.15
0.85
Upper GI
0.00
1.11
1.000
1.000
-0.31
0.31
Lower GI2
0.35
1.14
0.000
0.016
0.03
0.67
BM2
0.50
0.96
0.000
0.000
0.23
0.77
Head_neck
0.01
1.05
0.935
1.000
-0.29
0.30
Migrane
0.05
1.18
0.612
1.000
-0.28
0.38
Coccyx
-0.13
1.07
0.150
1.000
-0.43
0.17
Eating2
0.35
1.24
0.001
0.045
0.00
0.70
Drinking
0.02
1.10
0.815
1.000
-0.29
0.33
Back
0.01
1.11
0.877
1.000
-0.30
0.33
GI symptoms1
0.18
0.58
0.000
0.003
0.05
0.32
Nausea
0.29
1.22
0.006
0.215
-0.05
0.64
Vomit
-0.04
0.88
0.627
1.000
-0.28
0.21
GI_spasm
-0.01
0.97
0.860
1.000
-0.29
0.26
Constipation
0.06
0.90
0.448
1.000
-0.19
0.31
Diarrhea
0.26
1.14
0.010
0.354
-0.06
0.58
BS_JLM
0.04
0.96
0.592
1.000
-0.22
0.31
Gas_bloat_dist2
0.39
1.32
0.001
0.028
0.02
0.76
Inc_sounds2
0.41
1.14
0.000
0.002
0.09
0.73
No_BM
0.07
1.10
0.437
1.000
-0.24
0.38
Ab_BM
0.01
1.22
0.889
1.000
-0.33
0.36
Eat_bloat2
0.45
1.51
0.001
0.025
0.03
0.88
Medication
-0.03
1.39
0.804
1.000
-0.35
0.29
Meds
-0.03
1.39
0.804
1.000
-0.42
0.36
Quality of life
0.10
0.77
0.126
0.759
-0.08
0.28
Off_work
0.13
1.19
0.218
1.000
-0.21
0.46
Off_social
0.10
1.42
0.396
1.000
-0.30
0.50
Off_sex
0.12
1.37
0.313
1.000
-0.27
0.51
Off_daily_function
0.25
1.38
0.036
1.000
-0.14
0.64
Off_eat_out
0.34
1.23
0.002
0.059
-0.01
0.69
Massage_worry
-0.31
1.19
0.003
0.104
-0.65
0.02
Worry
0.06
1.07
0.521
1.000
-0.24
0.36
Pain severity
0.23
1.46
0.064
0.382
-0.10
0.57
Duration_pain
0.33
1.24
0.003
0.105
-0.02
0.68
Recent_max_pain
0.24
2.62
0.295
1.000
-0.50
0.97
Recent_min_pain
0.35
2.17
0.064
1.000
-0.26
0.96
Recent_avg_pain
0.02
1.89
0.892
1.000
-0.51
0.55
1Denotes domains for which average scores (over all questions within a domain) are significantly different between the initial and the follow-up survey, controlling the familywise error rate (over the 6 domains) at 5%.
2Denotes questions for which scores are significantly different between the initial and the follow-up survey, controlling the familywise error rate (over the 37 questions included in the SBO-Q) at 5%.
SBO-Q: Small Bowel Obstruction Questionnaire was administered. Table 3 shows a significant difference (multiplicity-adjusted P<0.05) in mean domain scores for the Pain and GI Symptoms domain. However, the lower bounds of the corresponding confidence intervals for the mean difference in domain scores are close to zero (0.02 and 0.05, respectively), indicating that, while statistically significant, the actual improvement may be very small.
A further analysis of the individual survey questions shows that within the Pain domain, General, Lower GI, BM, and Eating pain improved significantly between the initial and follow-up surveys. However, note the small lower bounds for the corresponding confidence intervals for the mean difference, indicating very small changes except perhaps for BM and General pain. The significant improvement in those two could reflect a time effect, the perceived pain lessening over time. Similarly, the three significant differences for individual questions in the GI Symptoms domains all have very small lower bounds of corresponding confidence intervals. For all other domains and all other individual survey questions within domains, no significant differences emerged (multiplicity-adjusted P-values > 0.05). The diet domain had a multiplicity-adjusted P=0.425, the Medication domain P=0.804, and the QOL domain P=0.126, all indicating no major changes in symptoms over the three-month period studied. For the CPA group, Table 4 shows significant differences for all domains (multiplicity-adjusted P-value < 0.05) except for the Medication domain (multiplicity-adjusted).
Domain question
Change mean, St. Dev
RawP–value
Multiplicity-adjusted P-value
Lower confidence bound
Upper confidence bound
Diet1
0.77
1.03
0.000
0.000
0.49
1.04
Liquid2
0.49
1.19
0.000
0.003
0.10
0.87
Soft2
0.71
1.38
0.000
0.000
0.26
1.16
Solid2
0.91
1.70
0.000
0.000
0.35
1.47
Anything2
0.98
1.66
0.000
0.000
0.44
1.53
Pain1
0.52
0.73
0.000
0.000
0.33
0.72
General2
0.88
1.41
0.000
0.000
0.43
1.34
Upper GI2
0.85
1.34
0.000
0.000
0.41
1.29
Lower GI2
0.58
1.49
0.000
0.005
0.10
1.07
BM2
0.49
1.08
0.000
0.001
0.13
0.85
Head_neck
0.39
1.39
0.005
0.201
-0.06
0.85
Migrane
0.11
0.69
0.117
1.000
-0.12
0.34
Coccyx
0.16
0.75
0.035
1.000
-0.09
0.41
Eating2
0.68
1.51
0.000
0.001
0.18
1.17
Drinking2
0.46
1.26
0.000
0.013
0.05
0.87
Back2
0.59
1.29
0.000
0.000
0.17
1.01
GI symptoms1
0.44
0.68
0.000
0.000
0.26
0.62
Nausea2
0.53
1.13
0.000
0.000
0.16
0.90
Vomit
0.17
0.58
0.003
0.113
-0.02
0.36
GI_spasm
0.20
0.89
0.026
0.979
-0.09
0.49
Constipation2
0.54
1.48
0.000
0.013
0.06
1.03
Diarrhea2
0.41
1.19
0.001
0.028
0.02
0.79
BS_JLM
0.06
1.01
0.559
1.000
-0.27
0.39
Gas_bloat_dist2
0.72
1.46
0.000
0.000
0.24
1.19
Inc_sounds
0.37
1.35
0.008
0.286
-0.08
0.81
No_BM2
0.56
1.36
0.000
0.003
0.11
1.01
Ab_BM2
0.63
1.54
0.000
0.003
0.13
1.14
Eat_bloat2
0.71
1.39
0.000
0.000
0.26
1.17
Medication
0.40
1.84
0.029
0.176
-0.09
0.89
Meds
0.40
1.84
0.029
1.000
-0.20
1.00
Quality of life1
0.78
0.85
0.000
0.000
0.55
1.01
Off_work2
0.42
0.91
0.000
0.000
0.12
0.72
Off_social2
0.78
1.29
0.000
0.000
0.36
1.21
Off_sex2
0.61
1.45
0.000
0.003
0.12
1.10
Off_daily_function2
0.99
1.40
0.000
0.000
0.53
1.45
Off_eat_out2
0.64
1.38
0.000
0.000
0.19
1.09
Massage_worry2
0.75
1.82
0.000
0.003
0.15
1.34
Worry2
1.32
1.64
0.000
0.000
0.78
1.85
Pain Severity1
1.51
1.66
0.000
0.000
1.07
1.95
Duration_pain2
1.21
1.86
0.000
0.000
0.61
1.82
Recent_max_pain2
2.70
3.26
0.000
0.000
1.62
3.78
Recent_min_pain2
0.65
1.82
0.001
0.023
0.04
1.25
Recent_avg_pain2
1.20
1.97
0.000
0.000
0.55
1.86
1Denotes domains for which average scores (over all questions within a domain) are significantly different between the initial and the follow-up survey, controlling the familywise error rate (over the 6 domains) at 5%.
2Denotes questions for which scores are significantly different between the initial and the follow-up survey, controlling the familywise error rate (over the 37 questions) at 5%.
(P-value = 0.176). The domain confidence intervals indicate that the mean difference in the average Diet and Quality of Life score falls somewhere between 0.5 and 1.0 on the 5-point scale, which is a rather large average effect. (For comparison, in the control group, no significant differences were reported for these two domains. Further, the difference in the average Pain Severity score was significant, ranging from 1.07 to 1.95. (For the control group, there was no significant difference.)
Overall, in the CPA group, 29 out of 37 survey questions showed a significant difference (in fact, improvement), compared to just 7 in the control group. Judging by the confidence intervals (CIs), some of the greatest improvements were seen in the Pain, QOL, and Diet domains. In the Pain Domain, notable improvements occurred for the questions “Experience of pain in general” (CI: 0.43-1.34), “Experience pain in the upper GI region” (CI: 0.41-1.29), “Recent Maximum Pain” (CI: 1.62-3.78), and “Duration of Pain” (CI: 0.61-1.82).
Patients who have undergone the significant trauma of SBO, accompanied by long hospital stays (average 14.2 d[5]), followed by invasive surgeries and recovery from those events, have significant “QOL” concerns afterwards. With regard to the QOL domain, some noteworthy large differences between the initial and follow-up survey were observed for the question “How often the subject worries about another SBO” (CI: 0.78-1.85), “How often the subject was unable to perform daily functions” (CI: 0.53-1.45), and “How often the subject was unable to attend social events” (CI: 0.36-1.21). Related to QOL.
Baseline 90d/90d post treatment
Diet
Pain
GI
QOL
Medication
Diet
Pain
GI
QOL
Medication
Quartiles for control subjects
Normal
44
16
24
4
100
34
24
26
12
100
Mild
54
76
79
37
27
61
80
86
22
24
Moderate
24
41
29
59
9
30
29
22
78
12
Severe
14
3
4
36
0
11
3
2
24
0
Quartiles for CPA treated subjects
Normal
24
47
50
22
71
52
74
74
60
82
Mild
21
27
34
39
7
26
22
20
26
3
Moderate
35
24
15
27
25
16
6
8
9
18
Severe
23
5
4
15
0
9
1
1
8
0
But analyzed under the Diet domain, the question about “The ability to eat anything” also showed some large improvements (CI: 0.44-1.53).
When the total number of subjects per SBO-Q domain is assessed for both questionnaires for the quartiles indicating the degree of impact (normal, mild, moderate, and severe), it was observed that the general trend demonstrated more subjects reporting experiences corresponding to no impact or normal for the quartiles in the CPA treatment group than the control group (Table 5). The significance observed in the individual question score analysis is also observed in this representation of the data, showing the clinical significance of these changes in the CPA treated group.
Trunk range of motion
All CPA treated subjects underwent a comprehensive physical therapy initial evaluation that included measurements for range of motion (ROM). It has been previously demonstrated that a significant improvement in ROM in the trunk was observed in patients with a history of SBO and may be a positive predictor for outcome. Included in these measurements are: trunk flexion; trunk extension; left and right side bending; left and right trunk rotation[40,42-44].
Every subject who presented with decreased ROM demonstrated improvement for at least one of the measurements presented in Table 6. Furthermore, 31.47% of total measurements were within the normal range after CPA treatment compared to 19.74% before treatment. Although not all subjects had a normal ROM for all measures after treatment, all subjects demonstrated overall improvements.
Statistical analysis of changes showed a significant increase in the mean ROM after treatment compared to before for all six measures (multiplicity-adjusted P-values< 0.05).
Patients with a history of SBO and surgery often presented with a kyphotic posture; we surmised this was due to the pull of abdominal adhesions, creating a forward flexion of the trunk. The improvement in trunk extension following CPA treatment suggests that adhesions in the abdomen and pelvis that prevented the subject from bending backwards or standing upright prior to therapy diminished enough to show significant improvement in trunk extension following the manual treatment. The improvements in side bending and rotation also suggest that decreasing adhesions in the abdomen and pelvis allowed improved trunk ROM. These findings indicate that improvements in trunk ROM measurements may be suitable as a predictor for the degree of adhesion deformation post CPA treatment.
Disease scoring
The observations made by the therapists at the initial evaluation and after CPA treatment were utilized to generate an objective numerical value for analysis of the overall state of the adhesive disease of the treated subjects. This numerical score takes into account the entire patient, assessed from head to toe, and includes ROM, organ motility, standard physical therapy tests, posture, and tissue response, with a range from 0 (no disease or deficiencies) to 1.0 (maximum disease) (supplemental Table 1). A total of 101 subjects in the CPA treated group were included in the assessment; results showed significant improvement in the full-body disease score. Prior to CPA treatment, the average disease score was 0.65 ± 0.11 (range 0.37-0.95) compared to post CPA treatment 0.29 ± 0.10 (range 0.1-0.53) (P< 0.001). This measure correlates well with both the ROM measures (Table 6 and the changes observed in the quartiles post CPA treatment in Table 5.
DISCUSSION
It is widely accepted that the adhesions that cause SBO and symptomology in subjects are often caused by prior abdominal or pelvic surgery[10,46]. This study is the first controlled study of a specific physical therapy protocol known as the Clear Passage Approach (CPA) in subjects with a history of SBO. The results of this study are very similar to those reported in an earlier uncontrolled efficacy study and case reports using the CPA to treat subjects with recurring SBO[35]. In all measures, the subjects treated with the CPA experienced significant improvements as compared to their baseline.
Range of motion measure (normal)
Pretreatment (n=103) Post-treatment (n=103) mean (SD) mean (SD) Number with normal ROM Number with normal ROM
RawPvalue
Multiplicity-adjusted-Pvalue
Lower confidencebound
Multiplicity-adjusted P-value
Flexion (80)
76.9 (19.4)
82.5 (15.1)
< 0.001
0.010
-10.4
-0.7
48
74
Extension (25)
25.2 (13.7)
29.9 (11.8)
< 0.001
< 0.001
-7.8
-1.5
45
77
Left side bending (45)
38.0 (10.3)
42.6 (8.7)
< 0.001
< 0.001
-7.2
-2.1
37
59
Right side bending (45)
38.8 (12.2)
43.4 (8.7)
< 0.001
< 0.001
-7.4
-1.8
47
62
Left rotation (45)
37.0 (14.8)
44.2 (14.4)
< 0.001
< 0.001
-10.4
-4
23
47
Right rotation (45)
39.3 (13.6)
45.5 (12.3)
< 0.001
< 0.001
-9.5
-2.9
44
70
ROM: Range of motion.
Before CPA treatment, and when compared to untreated controls. Manual physical therapy can provide adjunct therapy for known adhesions where there is no other available therapy proven to decrease recurrent SBO or to treat pain associated with adhesive disease. Unlike surgical procedures, adhesions do not appear to occur after treatment with the CPA[28].
Because treatment group participants had more complex histories and symptoms, their improvements likely had more of an impact on daily function than subjects in the control group. The results from this study suggest that the CPA can be used to treat adhesions and scar adherence safely in the recurrent SBO subject population, demonstrating significant improvements in overall pain, severity of pain, QOL, and number of episodes of SBO as compared to untreated subjects. Further, subjects who were previously concerned about having another SBO episode reported a significant decrease in that concern three months after treatment. In addition, the cost savings from using a relatively inexpensive outpatient treatment in place of surgery to prevent future obstruction, hospitalization, and surgery are worthy of consideration.
Based upon changes in range of motion and disease scores, it is inferred that tissue and organ mobility were improved as the subjects demonstrated an increased range of motion in active movement tests. Improvements in range of motion allowed subjects to perform daily tasks more easily and contributed positively to their overall QOL. The limitations of this study include the lack of randomization and a sham treatment group. A sham treatment is challenging to accomplish in a study such as this, where the treatment is 20 h of manual therapy over the course of one week. Indirect measures used to assess adhesions in the subjects, including improvement in self-reported symptoms, ROM, and objective disease scoring, were used as outcome measures. While these measures are indirect, all correlated well with the post CPA treatment experiences and the decreased number of SBOs and surgeries in the treatment group, compared to the control group.
Today, when a patient is discharged after non-surgical (or surgical) Management of adhesive SBO, there is no therapy that can be prescribed to help reduce recurrence. Further, the quality of life for patients who have undergone SBO, with or without surgery, is often greatly compromised. Repeat surgery for SBO is widely regarded as a primary cause of recurring SBO. This technique appears to delay or obviate surgery for many patients who have undergone the trauma of SBO, at a fraction of the cost of surgery. It offers a therapy where none is currently available. The CPA therapy appears to be a viable conservative option for patients who previously were told that there was nothing that they could do to reduce their chances of recurrent SBO.
Research background
Manual physiotherapy (mPT), called “manual physical therapy” in the United States, has been used to treat a wide variety of adhesive conditions, including burns, adhesive capsulitis, radiculopathy, pain, and the lessening of scars. In pilot studies, independent radiologic reports showed that the Clear Passage Approach (CPA), a specialized mPT performed in an outpatient setting, cleared bowel stricture and obstruction, obviating the need for planned surgical adhesiolysis and bowel resection. In case-control and efficacy studies, CPA demonstrated effectiveness in decreasing adhesions and pain, and improving quality of life (QOL) in subjects with recurrent small bowel obstruction (SBO).
Surgery is often cited as a primary cause of recurrent SBO due to the formation of post-operative adhesions. If a non-invasive outpatient therapy can decrease recurrent SBO and reduce the need for additional surgeries, it can improve quality of life for patients, with lower risk and decreased cost.
Research motivation
Adhesions that form after surgery present major problems for physicians and their patients. Surgeons note that adhesion barriers and gels are not always effective at preventing recurrent adhesions. The opportunity to delay or prevent post-surgical adhesions that can cause pain and recurring bowel obstruction is profound for patients. Many people live in fear that another major surgery or death could occur at any time, due to a recurrent obstruction.
Research objectives
The study has two main objectives: (1) to determine whether manual physiotherapy can lower the rate of repeat SBO in patients who have undergone prior adhesive bowel obstructions and surgeries; and (2) to examine whether the therapy can improve the quality of life of these patients, using a validated test.
Research methods
This is a controlled phase two study in which 103 subjects with a history of recurrent adhesive SBO were treated with a manual physical therapy called the CPA. The focus of the therapy was to decrease adhesive crosslinking in the abdominopelvic viscera. Pre- and post-therapy data measured recurring obstructions and quality of life using a validated test sent 90 days after therapy. Results were compared to 136 untreated control subjects who underwent the same measurements, but who did not receive any therapy. Until this method was developed, physical therapy had never been investigated as a course to treat recurring SBO.
Research results
Despite histories of more prior hospitalizations, obstructions, surgeries, and years impacted by bowel issues, the 103 CPA-treated subjects reported a significantly lower rate of repeat SBO than 136 untreated controls (total obstructions P = 0.0003; partial obstructions P = 0.0076). Subjects treated with the therapy demonstrated significant improvements in five of six total domains in the validated Small Bowel Obstruction Questionnaire (SBO-Q). Domains of diet, pain, gastrointestinal (GI) symptoms, quality of life (QOL), and pain severity when compared to post CPA treatment were significantly improved (P< 0.0001). The medication domain did not change in the CPA treated group (P = 0.176). Numerous studies examine the use of mPT to decrease adhesions and pain, and to improve function for conditions in various parts of the body. Pilot studies that examine the use of CPA include independent radiographs of cleared bowel obstruction. In a 10-year retrospective study of using CPA to treat adhesion-related female infertility (n = 1392), CPA opened blocked fallopian tubes in 60.85% (143/235) of women diagnosed with total tubal occlusion. In a recent study, mPT was shown to disrupt bowel adhesions in a rat model.
This is the first controlled study of using manual physiotherapy to decrease adhesions in the bowel.
The availability of the therapy is presently limited to private outpatient clinics in the United States and the United Kingdom, where therapists have been fully trained and certified in the CPA.
Research conclusions
Manual physiotherapy significantly improved the quality of life and significantly decreased the rate of re-occlusion for patients with a history of SBO. Performed in an outpatient setting, the non-invasive therapy significantly reduced repeat obstructions. In addition, physical therapy has a much lower risk and cost than hospitalization or surgery.
The study proposes that manual physiotherapy, which is commonly used to decrease adhesions in a variety of conditions, may be useful to decrease adhesions in the bowel. As such, it may delay or prevent recurring SBO.
This study noted that: (1) Post-surgical adhesions are frequently cited as the primary cause of SBO; (2) average costs in the United States for adhesiolysis and SBO are $65955 and $114175, respectively; (3) average hospital stays for adhesiolysis and SBO are 8.4 d and 14.2 d, respectively; (4) costs for a novel non-surgical physiotherapy to address adhesions and SBO are less than $7000; (5) Subjects treated with the therapy reported a significantly lower rate of repeat SBO than the untreated controls (total obstructions P = 0.0003; partial obstructions P = 0.0076); (6) subjects treated with the therapy demonstrated significant improvements in five of six total domains in the validated SBO-Q; (7) statistical analysis showed a significant increase in all six measures of trunk range of motion (flexion, extension, left and right side bending, left and right rotation.)
Manual physiotherapy significantly decreased the rate of recurrent small bowel obstruction (SBO) and improved the quality of life for patients with a history of prior SBO. Based on the decreased number of recurring obstructions and the measurable improvements in trunk range of motion, this manual physiotherapy can significantly improve outcomes and quality of life for patients who undergo abdominal or pelvic surgery to treat adhesions or SBO.
This study proposes the use of a specialized manual physiotherapy, the CPA, to delay or prevent recurring SBO. This study confirmed and quantified hypotheses from earlier pilot studies that CPA could increase QOL, delay or prevent recurring SBO, and delay or obviate the need for additional surgery for patients with recurring SBO, with less risk and a lower cost than the present model. The major implication for clinical practice is that physicians, who are often stymied by the frequent recurrence of adhesions and SBO following abdominal surgery or resection, now have a less risky and less costly alternative to repeat surgery.
Research perspectives
There is a place for a multi-disciplinary approach to a vexing problem for surgeons – the recurrence of adhesions and SBO following abdominal surgery or pelvic surgery. We hope to be able to quantify further the degree to which CPA can decrease the recurrence of SBO and the need for repeat surgeries. A prospective controlled study with closely matched study groups could be performed with the CPA method vs sham physiotherapy.
REFERENCES
Menzies D, Ellis H. Intestinal obstruction from adhesions – how big is the problem? AnnRCollSurgEngl1990; 72: 60-63 [PMID: 2301905]
Ten Broek RP, Issa Y, van Santbrink EJ, Bouvy ND, Kruitwagen RF, Jeekel J, Bakkum EA, Rovers MM, van Goor H. Burden of adhesions in abdominal and pelvic surgery: systematic review and meta-analysis. BMJ 2013; 347: f5588 [PMID: 24092941 DOI: 10.1136/bmj.f5588]
Strik C, Stommel MW, Schipper LJ, van Goor H, Ten Broek RP. Risk factors for future repeat abdominal surgery. Langenbecks Arch Surg 2016; 401: 829-837 [PMID: 27074725 DOI: 10.1007/ s00423-016-1414-3]
HCUPnet: A tool for identifying, tracking, and analyzing national hospital statistics. 2012; Available from: URL: http://hcupnet.ahrq.gov/HCUPnet.jsp?Id=6D36343307A90AD9Form=SelLAYJS=YA ction=%3E%3ENext%3E%3E_LAY=Researcher
Wilson MS, Ellis H, Menzies D, Moran BJ, Parker MC, Thompson JN. A review of the management of small bowel obstruction. Members of the Surgical and Clinical Adhesions Research Study (SCAR). Ann R Coll Surg Engl 1999; 81: 320-328 [PMID: 10645174]
Bingener J, Kazantsev GB, Chopra S, Schwesinger WH. Adhesion formation after laparoscopic ventral incisional hernia repair with polypropylene mesh: a study using abdominal ultrasound. JSLS2004; 8: 127-131 [PMID: 15119656]
Van Eijck FC, Wijnen RM, van Goor H. The incidence and morbidity of adhesions after treatment of neonates with gastroschisis and omphalocele: a 30-year review. J Pediatr Surg 2008; 43: 479-483 [PMID: 18358285 DOI: 10.1016/j.jpedsurg.2007.10.027]
Chelala E, Baraké H, Estievenart J, Dessily M, Charara F, Allé JL. Long-term outcomes of 1326 laparoscopic incisional and ventral hernia repairs with the routine suturing concept: a single-institution experience. Hernia 2016; 20: 101-110 [PMID: 26093891 DOI: 10.1007 /s10029-015-1397-y]
DiSaverio S, Coccolini F, Galati M, Smerieri N, Biffl WL, Ansaloni L, Tugnoli G, Velmahos GC, Sartelli M, Bendinelli C, Fraga GP, Kelly MD, Moore FA, Mandalà V, Mandalà S, Masetti M, Jovine E, Pinna AD, Peitzman AB, Leppaniemi A, Sugarbaker PH, Goor HV, Moore EE, Jeekel J, Catena F. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. WorldJEmergSurg2013; 8: 42 [PMID: 24112637 DOI: 10.1186/1749-7922-8-42]
Lorentzen L, Øines MN, Oma E, Jensen KK, Jorgensen LN. Recurrence After Operative Treatment of Adhesive Small-Bowel Obstruction. JGastrointestSurg2018; 22: 329-334 [PMID:29030779 DOI: 10.1007/s11605-017-3604-x]
Hajibandeh S, Hajibandeh S, Panda N, Khan RMA, Bandyopadhyay SK, Dalmia S, Malik S, Huq Z, Mansour M. Operative versus non-operative management of adhesive small bowel obstruction: A systematic review and meta-analysis. Int J Surg 2017; 45: 58-66 [PMID: 28728984 DOI: 10.1016/j.ijsu.2017.07.073]
Pismensky SV, Kalzhanov ZR, Eliseeva MY, Kosmas IP, Mynbaev OA. Severe inflammatory reaction induced by peritoneal trauma is the key driving mechanism of postoperative adhesion formation. BMC Surg 2011; 11: 30 [PMID: 22082071 DOI: 10.1186/1471-2482-11-30]
Arung W, Meurisse M, Detry O. Pathophysiology and prevention of postoperative peritoneal adhesions. WorldJGastroenterol2011; 17: 4545-4553 [PMID: 22147959 DOI: 10.3748/wjg.v17.i41.4545]
Yigitler C, Karakas DO, Kucukodaci Z, Cosar A, Gülec B, Akin ML. Adhesion-preventing properties of 4% icodextrin and canola oil: a comparative experimental study. Clinics(Sao Paulo) 2012; 67: 1303-1308 [PMID: 23184208 DOI: 10.6061/clinics/2012(11)14]
Cheong YC, Shelton JB, Laird SM, Richmond M, Kudesia G, Li TC, Ledger WL. IL-1, IL-6, and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions. Hum Reprod2002; 17: 69-75 [PMID: 11756364 DOI: 10.1093/humrep/17.1.69]
tenBroek RP, Wilbers J, van Goor H. Electrocautery causes more ischemic peritoneal tissue damage than ultrasonic dissection. SurgEndosc 2011; 25: 1827-1834 [PMID: 21140171 DOI: 10.1007/ s00464-010-1474-3]
Lauder CI, Garcea G, Strickland A, Maddern GJ. Abdominal adhesion prevention: still a sticky subject? Dig Surg 2010; 27: 347-358 [PMID: 20847564 DOI: 10.1159/000314805]
Sucher BM. Ultrasonography-guided osteopathic manipulative treatment for a patient with thoracic outlet syndrome. J Am Osteopath Assoc 2011; 111: 543-547 [PMID: 21955534 DOI: 10.7556/jaoa. 2011.111.9.543]
Sampson S, Meng M, Schulte A, Trainor D, Montenegro R, Aufiero D. Management of Dupuytren contracture with ultrasound-guided lidocaine injection and needle aponeurotomy coupled with osteopathic manipulative treatment. J Am Osteopath Assoc 2011; 111: 113-116 [PMID: 21357497]
Boyles R, Toy P, Mellon J Jr, Hayes M, Hammer B. Effectiveness of manual physical therapy in the treatment of cervical radiculopathy: a systematic review. JManManipTher2011; 19: 135-142 [PMID: 22851876 DOI: 10.1179 /2042618611Y.0000000011]
Bayliss AJ, Klene FJ, Gundeck EL, Loghmani MT. Treatment of a patient with post-natal chronic calf pain utilizing instrument-assisted soft tissue mobilization: a case study. J Man Manip Ther 2011; 19: 127-134 [PMID: 22851875 DOI: 10.1179/2042618611Y.0000000006]
Şenbursa G, Baltaci G, Atay ÖA. The effectiveness of manual therapy in supraspinatus tendinopathy. Acta Orthop Traumatol Turc 2011; 45: 162-167 [PMID: 21765229 DOI: 10.3944 AOTT.2011.2385]
Wurn LJ, Wurn BF, King CR, Roscow AS, Scharf ES, Shuster JJ. Increasing orgasm and decreasing dyspareunia with a manual physical therapy technique. MedGenMed2004; 6: 47 [PMID:15775874]
Wurn BF, Wurn LJ, Patterson K, King CR, Scharf ES. Decreasing dyspareunia and dysmenorrhea in women with endometriosis via manual physical therapy: Results from two independent studies. JEndometr 2011; 3: 188-96 [DOI: 10.5301/JE.2012.9088]
Wurn BF, Wurn LJ, King CR, Heuer MA, Roscow AS, Scharf ES, Shuster JJ. Treating female infertility and improving IVF pregnancy rates with a manual physical therapy technique. MedGenMed 2004; 6: 51 [PMID: 15266276]
Kramp ME. Combined manual therapy techniques for the treatment of women with infertility: a case series. JAmOsteopathAssoc 2012; 112: 680-684 [PMID: 23055467]
Bove GM, Chapelle SL. Visceral mobilization can lyse and prevent peritoneal adhesions in a rat model. J Bodyw Mov Ther 2012; 16: 76-82 [PMID: 22196431 DOI: 10.1016/j.jbmt.2011.02.004]
Chapelle SL, Bove GM. Visceral massage reduces postoperative ileus in a rat model. J Bodyw Mov Ther 2013; 17: 83-88 [PMID: 23294688 DOI: 10.1016/j.jbmt.2012.05.004]
Rice AD, Wakefield LB, Patterson K, Reed ED, Wurn BF, King CR 3rd, Wurn LJ. Decreasing adhesions and avoiding further surgery in a pediatric patient involved in a severe pedestrian versus motor vehicle accident. Pediatr Rep 2014; 6: 5126 [PMID: 24711912 DOI: 10.4081/pr.2014.5126]
Rice AD, King R, Reed ED, Patterson K, Wurn BF, Wurn LJ. Manual Physical Therapy for Non-Surgical Treatment of Adhesion-Related Small Bowel Obstructions: Two Case Reports. JClinMed2013; 2: 1-12 [PMID: 26237678 DOI: 10.3390/jcm2010001]
Rice AD, Patterson K, Reed ED, Wurn BF, Klingenberg B, King CR 3rd, Wurn LJ. Treating Small Bowel Obstruction with Manual Physical Therapy: A Prospective Efficacy Study. Biomed Res Int 2016; 2016: 7610387 [PMID: 26989690 DOI: 10.1155/2016/7610387]
Rice AD, Reed ED, Patterson K, Wurn BF, Wurn LJ. Clearing bowel obstruction and decreasing pain in a terminally ill patient via manual physical therapy. JPalliatMed2013; 16: 222-223 [PMID: 23362839 DOI: 10.1089/jpm. 2012.0458]
Rice AD, Wakefield LB, Patterson K, D’Avy Reed E, Wurn BF, Klingenberg B, King Iii CR, Wurn LJ. Development and Validation of a Questionnaire to Measure Serious and Common Quality of Life Issues for Patients Experiencing Small Bowel Obstructions. Healthcare(Basel) 2014; 2: 139-149 [PMID: 27429266 DOI:10.3390/healthcare2010139]
A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. 2017
Glossary of Osteopathic Terminology. 2011; Available from: http://www.aacom.org/resources/bookstore/Documents/GOT2011ed.pdf
Norkin CC, White DJ. Measurement of Joint Motion: A Guide to Goniometry. 2nd ed. Philadelphia: F.A. Davis Company; 1995
Senbursa G, Baltaci G, Atay A. Comparison of conservative treatment with and without manual physical therapy for patients with shoulder impingement syndrome: a prospective, randomized clinical trial. Knee Surg Sports Traumatol Arthrosc 2007; 15: 915-921 [PMID: 17333123 DOI: 10.1007/s00167-007-0288-x]
Kendall F, McCreary E. Muscles: Testing and Function. 3rd ed. Baltimore: Williams & Wilkins; 1983
Surgeons AA of O, editor. Joint Motion: Method of Measuring and Recording. Chicago: AAOS; 1965
Hoppenfield S. Physical Examination of the Spine and Extremities. New York: Appleton-Century-Crofts; 1976
Westfall, P., Young, S. Resampling-based multiple testing: Examples and methods for p-value adjustment. New York: Wiley; 1993
Brüggmann D, Tchartchian G, Wallwiener M, Münstedt K, Tinneberg HR, Hackethal A. Intra-abdominal adhesions: definition, origin, significance in surgical practice, and treatment options. DtschArzteblInt2010; 107: 769-775 [PMID: 21116396 DOI:10.3238/arztebl.2010.0769]
P-Reviewer: Delibegovic S, Kaya DO, Ünver B S-Editor: Wang XJ
L- Editor: A E-Editor: Huang Y
Reproduced under Creative Commons license; highlights added. Published by Baishideng Publishing Group Inc., 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA; Telephone: +1-925-223-8242; Fax: +1-925-223-8243; E-mail: bpgoffice@wjgnet.com; http://www.wjgnet.com
Belinda F. Wurn, PT; Lawrence J. Wurn, LMT; C. Richard King, MD; Marvin A. Heuer, MD;
Amanda S. Roscow, MPT; Kimberley Hornberger, PTA, LMT; Eugenia S. Scharf, PhD
Disclosure: Therapy was performed and data gathered at Clear Passage Therapies, Inc., in Gainesville, Florida, which funded the study. The company is owned by Belinda F. Wurn, PT, and Lawrence J. Wurn, LMT. Amanda S. Roscow, MPT, and Kimberley Hornberger, PTA, LMT, are employees of Clear Passage Therapies. Eugenia S. Scharf, PhD, received an honorarium for her services. C. Richard King, MD, and Marvin A. Heuer, MD, have no financial or proprietary interest in the subject matter or materials discussed.
Belinda F.Wurn, PT, is the national director of services at Clear Passage Therapies, Inc., Gainesville, Florida. Lawrence J. Wurn, LMT, is the director of clinical studies at ClearPassage Therapies. C. Richard King, MD, is a gynecological surgeon with Southeastern Women’s Health and the medical director at Florida Medical and Research Institute, Gainesville.Marvin
A. Heuer, MD, is the chief scientific officer at Iovate Health Sciences, Inc., Toronto, Ontario, and associate clinical professor, Department of Family Medicine and Community Health, University of Florida, Gainesville. Amanda S.Roscow, MPT, is the clinical director, and Kimberley Hornberger, PTA, LMT, is a therapist at Clear Passage Therapies. Eugenia S. Scharf, PhD, is a freelance medical writer/editor/researcher in Gainesville.
It is generally agreed that adhesions within the fallopian tubes are a major cause of infertility.1 Pelvic adhesions may negatively impact the efficacy of in vitro fertilization (IVF) and other assisted reproductive techniques.2 Many gynecologists concur that when the occlusion is caused by
pathology (vs spasms), the tubes rarely, if ever, spontaneously reopen. Although some contend that diagnostic hysterosalpingo-grams (HSGs) may themselves enhance fertility, others proclaim this a myth, and the debate continues.3 Moreover, despite the variety of surgical procedures to correct tubal adhesions, the optimal treatment of infertility due to tubal occlusion has not been established.4
Tubal adhesions are most often caused by previous abdominopelvic surgery, endometriosis, infection, polyps, ectopic pregnancy, and chronic inflammation.5,6 At 1 to 2 months post-injury, collagen fibrils organize into discrete bundles that eventually mature into a fibrous band. Collagen cross-links may evolve from microadhesions to adhesions to scars. Ironically, the adhesions formed as a byproduct of healing after surgical procedures to open blocked fallopian tubes may themselves be a cause of the high tubal reocclusion rates over time.7
The ability of manual therapy to effect structural change in adhesions is supported by the basic literature on mechanical tissue
testing, as well as connective tissue physiology and remodeling. In brief, specific sustained physical force applied to a given area has been shown to alter connective tissue length and mobility.8,9 Theoretically, soft-tissue mobilization creates microfailure of the collagenous cross-links that cause pain and dysfunction and hence can affect restoration of normal mobility and function to previously adhered structures.
The purpose of this retrospective analysis was to determine the efficacy of a manual soft-tissue therapy in increasing tubal mobility and function in women with total bilateral tubal occlusion and a gynecologic history indicating likely pelvic adhesion formation. Since an individual’s subfertility may be a function of concurrent factors, the therapy also addressed (by default) probable adhesions affecting neighboring reproductive organs and adjacent structures.10,11
METHODS
The soft-tissue techniques used in this study were developed after extensive investigation of current, innovative physical therapy methods, including techniques taught and endorsed by the American Physical Therapy Association (APTA). The encouraging results obtained in prior retrospective and prospective investigations10 prompted this retrospective analysis of the therapy’s efficacy in treating tubal occlusion. All therapists had met the criteria for certification in the use of this therapy.
PatientSelection
A total of 28 infertile women, self-selected from the general population, were evaluated and treated over a 3-year period. Patients presented with a variety of symptoms appropriate to women’s health physical therapy (eg, dyspareunia, dysmenorrhea, incontinence, chronic pelvic pain).
The primary criteria for inclusion in this analysis were the following: (1) a history indicative of abdominopelvic adhesions;
(2) documented complete bilateral tubal occlusion (ie, no spillage of contrast medium) or unilateral occlusion if the contralateral tube had been surgically removed before treatment; and (3) documented radiologic, surgical, or pregnancy reports after treatment. Pre-treatment diagnoses of tubal occlusion were made by laparoscopy or laparotomy with chromotubation or HSG as reported by the patients’ physicians, along with a description of the extent and type (proximal, midtubal, distal, combination) of tubal blockage.
In addition to the diagnostic reports of tubal occlusion and histories indicating probable abdominopelvic adhesions, these patients met the US requirement for infertility by failing to achieve a natural intrauterine pregnancy after a minimum of 1 year of unprotected intercourse. None were excluded from this analysis on the basis of such potentially confounding variables as hormonal problems, hydrosalpinx, advanced age, or (possible) male factor.
Follow-up data were obtained via radiologic, surgical, and pregnancy reports. The 28 (primarily Caucasian) patients ranged in age from 26 to 43 years. Mean age was 35.2 (median, 36); mean duration of infertility was 4.7 years (median=2.0), and the mean body mass index was 24.3.
Including the 3 subjects with only 1 tube (the functional equivalent of bilateral occlusion), the types of tubal occlusion were as follows:
proximal occlusion in both tubes or equivalent (n=12);
midtubal occlusion in both tubes (n=5);
distal occlusion in both tubes or equivalent (n=6); and
Patient histories were obtained from medical records and included physical therapy and biomechanical assessments; gynecological, surgical, and trauma history; and prior infertility tests, diagnoses, and treatments. Among the factors indicating a strong probability of pre-treatment abdominopelvic adhesion formation were abdominopelvic surgery (86%); infection/inflam-mation, including endometriosis (86%); trauma (78%); miscarriage (21%); and tubal pregnancy (18%).
StatisticalPlan
Although no formal sample size calculation was prospectively done, N=28 is typical of pilot studies. This sample size assures, with 95% confidence, estimation of a proportion within 20% of the true value.
Procedures
Because all patients had reported a variety of abdominopelvic problems (eg, pelvic and/or intercourse pain, menstrual cramps, endometriosis pain), their physical therapy treatment protocols were designed to address these conditions as well as tubal occlusion. The manual therapy (a protocol of soft tissue physical therapy) was described in more detail in an earlier study.10 The treatment team was composed of 5 therapists, all trained in this protocol to treat pelvic adhesions. The 28 subjects were treated by a combination of 2 or more therapists.
After reviewing patient histories and performing extensive manual palpation of the abdominopelvic region, the therapists determined the areas of decreased mobility. They then engaged the soft tissues by using their hands to apply a specific force to restricted structures (visceral, myofascial, and ligamentous) until they perceived a release of the cross-links. The fallopian tubes, which are very difficult to palpate, were accessed via external, internal, and bi-manual manipulation of more palpable neighboring soft tissue structures. Manual internal (vaginal) therapy has been practiced by US physical therapists to treat pelvic pain and incontinence since 1977, when the APTA Section on Obstetrics and Gynecology was created. It is common practice today and is taught and endorsed by the (renamed) APTA Section on Women’s Health.
To illustrate for non-specialists how our therapists were able to indirectly access the tubes, the following brief review of pelvic anatomy may be helpful. The fallopian tube is located in the superior aspect of the free margin of the broad ligament, between
the ovary and the round ligament. Due to the close anatomical relationship between the peritoneum and the ovary, any surgical, inflammatory, traumatic, or infectious damage to the peritoneum can affect ovarian or tubal function. At the sides of the uterus, 2 layers of peritoneum (from the anterior and posterior aspects of the uterus) join to form the broad ligament that extends to the lateral walls of the pelvis. The mesosalpinx is the part of the broad ligament that goes from the tube to the ovary and comprises the anterior and posterior layers of the peritoneum. The ovaries are attached to the posterior aspect of the broad ligament. The peritoneal mesovarium surrounds the ovaries and connects the superior ovary to the fimbriated end of the tubal infundibulum. Thus, there are sufficient structural elements attaching to the fallopian tubes via adjoining structures to allow indirect manipulations by the therapist.
The therapists palpated these soft tissues and assessed their texture, tension, and relative temperature while feeling for decreased elasticity, distensibility, or increased heat. They used their palpation skills to assess restrictions in these parameters in the tissues and organs surrounding the fallopian tubes by manipulating the peritoneum, uterine and ovarian ligaments, and neighboring structures.
In general, release was noted by a marked increase in soft-tissue mobility, extensibility, flexibility, and range of motion at the targeted sites after each therapy session. Further evidence of release included improved alignment and biomechanics, along with an increased range of motion of osseous and ligamentous soft tissue structures. Patients who had reported pain symptoms at their initial visit often reported pain relief during the course of treatment—presumably due to the decreasing tension and pressure on nerves and pain-sensitive structures and improved mobility of the structures during normal movements.
DataCollection
All 28 patients received manual physical therapy treatments for pelvic pain and/or adhesions, and each signed an informed consent agreeing to the compilation and (confidential) publication of her complete case history, treatment data, and results. Manual physical therapy is considered conservative and non-invasive and is included in Current Procedural Terminology, the official American Medical Association list of commonly accepted clinical procedures. Although its potential to facilitate fertility is a relatively new concept, manual physical therapy is commonly used by physical therapists to treat pain or adhesions (as in this case). The collection of existing data when patients cannot be identified is excluded from the requirements of institutional regulatory boards under 45CFR 46.101(b)(4).
In accordance with the standards of the APTA, detailed clinical records were kept of all patient visits, including symptomatic complaints, areas treated, treatment techniques performed, treatment dates, and duration.12. All but 4 patients completed the recommended 20-hour treatment within 1 month; 23 of 28 did so within 1 week. If a patient reported she was pregnant during the course of therapy, any remaining sessions were cancelled.
The standard therapy session was 1-2 hours, minus 15 minutes for room preparation and paperwork.
Because there is no agreed-upon estimate of how long tubes remain open (thus enabling pregnancy), an arbitrary decision was made to end the follow-up period 2 years after the patients’ last treatment dates. (Some studies allow a minimum 1-year follow-up; others continue for 2-5 years13 or longer.)
None of the 28 patients in this study received any other treatment (medical or integrative) for tubal occlusions while undergoing the manual therapy or in the interval between manual therapy and the post-therapy patency test (including pregnancy).
RESULTS
To evaluate the effectiveness of the therapy in treating tubal occlusion, the primary outcome measures were (1) confirmed tubal patency or natural intrauterine pregnancy and (2) natural intrauterine pregnancy within the 2-year follow-up period. Although the latter is assuredly the “gold standard” for tubal patency, a meta-analysis of HSG showed that its high specificity (0.83) makes it a “useful test for ruling in tubal obstruction.”14(p486) As mentioned previously, patients were treated by a combination of 2 or more therapists from the 5-person treatment team. Data analysis showed there were no observable differences in success rates among the various therapists.
Patency
Of the 28 participants, 17 (61%, 95% exact CI 41%-78%) demonstrated post-treatment unilateral or bilateral patency as measured by HSG (n=15) or natural intrauterine pregnancy (n=2). The mean interval between the last treatment date and patency con-firmation was 2 months (median=1 month).
In a preliminary attempt to determine if the treatment had equal efficacy for various types of tubal occlusion (proximal, distal, midtubal), the data were subdivided into 3 groups. Including the 3 women whose contralateral tube had been surgically removed, 23 of 28 subjects had the same type of obstruction in both tubes. Five women had occlusion “combinations” (ie, proximal/distal [n=4] or proximal/midtubal [n=1]) (Table 1).
The results were as follows: 8 of 12 (66.7%) patients with proximal lesions in both tubes demonstrated post-treatment patency, as did 3 of 6 (50%) patients with distal lesions; 2 of 5 (40%)
patients with midtubal lesions; and 4 of 5 (80%) patients with “combination” occlusion achieved patency. Of the 4 patients with a combination of proximal/distal occlusion, 2 achieved patency in both tubes, and 1 achieved patency only in the distally occluded tube. The 1 patient with proximal/midtubal occlusion achieved patency in the tube with midtubal obstruction.
Pregnancy
Of the 17 patent patients, 9 (53%; 95% exact CI 28%-77%) reported a natural or intrauterine insemination–assisted (n=1) intrauterine pregnancy by the end of the 2-year follow-up period. No ectopic pregnancies occurred in any of the patients. The mean interval between the last treatment date and confirmation of pregnancy was 11 months (median=9 months).
The natural intrauterine pregnancy rate for all treated patients was 32% (9 of 28). Any patient who demonstrated post-treatment total occlusion was automatically considered a failure in terms of (potential) pregnancy. Table 2 shows the relationship between the type of tubal occlusion and subsequent patency for the 9 pregnant patients. It is evident that clinical pregnancies were documented in all 3 (proximal, distal, midtubal) types of occlusion.
TABLE2Pregnancies* by Occlusion Type and Post-treatment Patency
Patient
Type of Occlusion
Post-treatmentPatency
1
proximal/proximal
patency via pregnancy
2
proximal/proximal
patency via pregnancy
3
proximal/proximal
1 tube opened
4
proximal/proximal
1 tube opened
5
proximal/proximal
1 tube opened
6
midtubal/midtubal
2 tubes opened
7
distal/removed
distal tube opened
8
proximal/distal
distal tube opened
9
proximal/distal
2 tubes opened
*Nine of 17 (53%) patients had an intrauterine pregnancy.
Effects of Age and Overweight/Obesity
Although no subjects were excluded from this analysis on the basis of advanced age or overweight/obesity, we suspected these variables might affect the outcomes. The statement, “a woman’s 35th birthday marks a watershed that irreversibly lowers the probability of reproduction in her life”1(p. 10), apparently holds true even in the various surgical/medical treatments of tubal obstruction.15 Thus, we looked at the patency and pregnancy data sets both by age group: <35 years vs 35+ and body mass index (BMI).
Age/Patency
As of their last treatment date, the mean age for the <35 group was 30.5 years (range=26-34), and the mean age for the
≥35 group was 39.2 years (range=35-43). Thus, the difference in mean age between the 2 groups was 8.7 years. The results showed that 10 of 13 (77%) patients <35 vs 7 of 15 (47%) patients ≥35 demonstrated post-treatment fallopian tube patency (Table 3).
Age/Pregnancy
As of the patients’ last treatment date, the mean age for the patient <35 group was 30.8 years (range=26-34), and the mean age for the patient≥35 group was 38.6 years (range=35-42). Thus, the difference in mean age between the 2 groups was 7.8 years. The results showed that 7 of 10 (70%) patients <35 vs 2 of 7 (29%) patients ≥35 achieved a post-treatment natural intrauterine pregnancy (Table 4).
TABLE4Pregnancies of Patent Patients by Age Group
Age
n
No.Pregnant
%Pregnant
<35*
10
7
70.0
≥35†
7
2
28.6
Total
17
9
52.9
*Mean=30.8 years; †mean=38.6 years.
Although we have no insights into why age affects tubal patency, the results suggest that the efficacy of this therapy was (as usual) considerably greater for the <35 group. Nevertheless, nearly half of the age ≥35 patients had 1 or both tubes opened, and 29% of these patent patients conceived by the end of the follow-up period.
Overweight/Obesity
Our primary concern was that structures as small and delicate as fallopian tubes would be more difficult to manipulate in overweight and obese women. Nine patients had a BMI of 25-29, and 2 had a BMI of >30; thus, 11 of 28 (39%) were overweight or obese. Somewhat to our surprise, 8 of 11 (73%) overweight patients (including both obese women) demonstrated post-therapy patency, suggesting that the therapists were able to indirectly access the tubes via the adjoining structures as described earlier. Because the fallopian tubes presumably would be more difficult to access in obese/overweight women, the effectiveness of the technique with overweight patients suggests that micro-manipulation of the fallopian tubes may be achieved via macro-manipulation (release of tension/adhesions/scar tissue) of the adjoining cardinal and broad ligaments.
TreatmentSafety
None of the patients reported any observable complications or adverse side effects as a result of their treatment.
DISCUSSION
The results indicate that manual soft-tissue therapy helped restore patency and function in women with tubal occlusion and a history indicating probable adhesion formation. Abdominopelvic adhesions are particularly relevant to several aspects of reproductive medicine, as outlined below:
Pelvic adhesions that interfere with access of the fallopian tubes to the ovaries are widely recognized as a major cause of infertility.1 Whereas some types of tubal obstruction can be considered a biomechanical reproductive organ dysfunction associated with an indication of pelvic adhesions, 1 study of falloscopic tuboplasty reported, “a high incidence of multiple adhesions was observed in the entire length of tubal lumen in patients having bilateral occlusion.”16(p71)
Tubal adhesions are a major factor affecting the success rates of medical/surgical procedures designed to facilitate fertility. For example, although a transvaginal fallopian tube catheterization study achieved a 100% successful catheterization rate for fallopian tube ostia and a 64% successful recanalization rate, the subsequent intrauterine pregnancy rate was only 11%. The authors concluded that “the higher incidence of adhesions in the patients’ background caused the low incidence of pregnancy.”17 (p. 49) A large-scale (n=246) investigation of background factors in relation to pregnancy outcomes after a variety of fertility surgery procedures (adhesiolysis, salpingostomy, tubal anastomoses, implantation, and myomectomy) also found that the extent of tubal damage was the most relevant factor in subsequent fertility, and that “adhesion formation is not negligible.”18(p281)
The adhesions that form as a byproduct of healing from the various invasive procedures may themselves be a cause of the high reocclusion rates over time. For example, a repeat HSG 6 months after an ambulatory, minimally invasive catheter procedure showed a total reocclusion rate in 35 of 43 (81%) patients.7
We believe a major strength of this retrospective analysis was its inclusive population. Patients were not excluded for conditions such as hydrosalpinx, hormonal problems, advanced age, overweight/obesity, duration of occlusion, prior removal of 1 tube, or possible male factor—any of which might have lowered the success rates.
Although the main weakness of this analysis may be the lack of an external control group, we did not consider one, as no published study of a standard surgical procedure compared its results to a planned “no treatment” control group. The rationale, presumably, is that occluded tubes do not spontaneously reopen. Thus, other than natural pregnancy, the only way to know if patency was achieved in a control group member must be via yet another diagnostic test. Although some researchers contend that a second diagnostic HSG may itself permit enhanced fertility in proximal occlusion cases, this ongoing debate is complicated by the oil-soluble vs water-soluble contrast agent issue.
In trying to determine the estimated patency rate of a relatively large untreated control group, however, we found a study in which participants enrolled on the basis of diagnosed proximal tubal occlusion (HSG and/or laparoscopy) underwent another HSG to confirm occlusion prior to receiving transcervical balloon tuboplasty (TBT). Eight percent (12 of 147) of the patients demonstrated patency, thereby forming a default control group for comparing pregnancy rates with the TBT-treated group.7 To compare: the patency rate in our retrospective analysis (61%; 17 of 28) differed from this (8%) historical control rate, P<.001 by chi-square analysis.
The fact that laparoscopy may be the more definitive means of diagnosing tubal obstructions notwithstanding, we could not insist that our “adhesion-ridden” patients undergo yet another potentially adhesion-inducing (and costly) surgery just to recon-firm the absence or presence of post-treatment occlusion.
Although the incidence of proximal tubal occlusion (PTO) represents just 20%-33% of all cases with tubal occlusion,5,19 considerable progress has been made in its treatment relative to the other types. Published reports, however, still show patency and pregnancy rates to be extremely variable. Direct comparisons of treatments are difficult as not all studies distinguish between intrauterine and ectopic pregnancies, and many surgical cases do report a sizable percentage of ectopic pregnancies after tuboplasty.
We did not originally distinguish between the 3 main types of tubal occlusion, so we are at a disadvantage in comparing our results with standard treatments (eg, microsurgical tubal anastomosis, tubal catheterization and recanalization, balloon tuboplasty), many of which deal only with PTO. Given the relatively small size of our (unplanned) subgroups, we chose to cite our total group results, which also included midtubal, distal, and combination cases.
Nearly every study of PTO shows a discrepancy in the success rates for patency and subsequent pregnancy. For example, although some contend that “pregnancy rate rather than tubal patency should be the measure by which transcervical tubal recanalization procedures are judged,”20 (p. 1425), there is no clear explanation of the widely varying pregnancy rates (7% to 61%) that have been reported.
Accordingly, we have arbitrarily limited comparison of our results to the putative largest study of infertile patients (total N=3424) treated with selective salpingography and balloon tuboplasty.21 A subgroup of 277 women with bilateral PTO but “no other identified cause for their infertility” (including distal disease or hydrosalpinges) were first treated with selective salpingography and, if that failed, with balloon tuboplasty. The median age was 27.8 years, and the combined success rates for patency and (all) subsequent pregnancies were 68% and 36%, respectively.21 Although the median age of our 28 subjects was 36.0 years (ie, 8 years older), the success rates for patency and subsequent intrauterine pregnancies were similar: 61% and 32%, respectively. Moreover, as mentioned above, no patients in our analysis were excluded on the basis of any “other identifiable causes” of infertility, including the more problematic midtubal and distal occlusion. The importance of distinguishing between types of tubal occlusion was shown by a large, multicenter transcervical balloon tuboplasty study that found that patients with PTO had sig-nificantly higher pregnancy rates than those with midtubal or distal obstruction.
The results of the few relatively recent studies of distal occlusion were most discouraging. Although one 1994 study of several laparoscopic treatments showed variable patency rates (33%-66%), the pregnancy rate was 19 of 81 (23%), of which only 10% were intrauterine pregnancies.22 Hence, many investigators have concluded that assisted reproductive techniques (eg, IVF) may represent the most effective means of treating patients with poor tubal status, severe adhesions, etc.4,13,23.
Although the number of subjects with bilateral (or equivalent) distal occlusion in our analysis was too small (n=6) to determine pregnancy rates, 3 of 6 (50%) patients with distal lesions in both tubes demonstrated post-treatment patency in the distally occluded tube, including the 2 patients whose second tube had been surgically removed. Moreover, 3 of the 4 women with a combination proximal/distal occlusion also demonstrated patency in the distally occluded tube. (Of these, 2 of 3 showed patency in both tubes.) Thus, 6 of 10 women (60%) with distal occlusion in 1 or both tubes showed post-treatment patency of a distally occluded tube. As shown in Table 2, patients 7 and 8 subsequently conceived via their previously occluded distal tube, and patient 9 (proximal/distal combination) may have done so.
Another noteworthy finding was that 4 of 8 (50%) patients with diagnosed hydrosalpinges showed post-treatment patency; 2 of these 4 patent patients had a subsequent intrauterine pregnancy.24 Incidentally, 8 of the 9 women shown to have achieved pregnancy had a subsequent live birth, including the 2 women with hydrosalpinx. Clearly, there is a need for a large-scale, randomized, controlled trial of this therapy.
In conclusion, there are various indications for a noninvasive manual soft-tissue physical therapy directed toward breaking down existing adhesions. This therapy has already been shown to decrease abdominopelvic pain and improve sexual function11 and IVF pregnancy rates10 and may prove similarly effective in treating tubal occlusion and facilitating subsequent fertility. The therapy may be used alone or in conjunction with other medical/surgical treatments (eg, various recanalization procedures).
Acknowledgments
The authors thank Jonathan J. Shuster, PhD, and Amy Burnette Parker for their technical assistance.
Maruyama M, Osuga Y, Momoeda M, Yano T, Tsutsumi O, Taketani Y. Pregnancy rates after laparoscopic treatment: Differences related to tubal status and presence of endometriosis. JReprodMed.2000;45(2):89-93.
Yun AJ. Enhanced fertility after diagnostic hysterosalpingography: the debate continues. AJRAmJRoentgenol.2005;184(1):347; author reply 347-348.
Nichols KP, Steinkampf MP. Tubal surgery vs in vitro fertilization for the treatment of infertility due to distal tubal occlusion. PrimCareUpdateObGyns.1998;5(4):168.
Diamond MP, Copperman AB. Treatment of disorders of the fallopian tube. In: Keye WR Jr, Chang RJ, Rebar RW, Soules MR, eds. Infertility: Evaluation and Treatment.Philadelphia: W.B. Saunders, 1995:474-482.
Gleicher N, Confin E, Corfman R, et al. The multicentre transcervical balloon tubo-plasty study: conclusions and comparison to alternative technologies. Hum Reprod. 1993;8(8):1264-1271.
Threlkeld AJ. The effects of manual therapy on connective tissue. Phys Ther.
Wurn BF, Wurn LJ, King R, et al. Treating female infertility and improving IVF pregnancy rates with a manual physical therapy technique. Medscape GenMed. 2004; 6(2):51. Available at http://www.medscape.com/viewarticle/480429. Accessed October 8, 2007.
Wurn LJ, Wurn BF, King CR, Roscow AS, Scharf ES, Shuster JJ. Increasing orgasm and decreasing dyspareunia with a manual physical therapy technique. Medscape Gen Med.2004;6(4):47. Available at http://www.medscape.com/viewarticle/493989. Accessed October 8, 2007.
American Physical Therapy Association. Guide to Physical Therapist Practice. 1st ed. Alexandria, VA: American Physical Therapy Association; 1997: Appendix 7-2, 7-3.
Laatikainen TJ, Tenhunen AK, Venesmaa PK, Apter DL. Factors influencing the success of microsurgery for distal tubal occlusion. ArchGynecolObstet. 1988;243(2):101-106.
Swart P, Mol BW, van der Veen F, van Beurden M, Redekop WK, Bossuyt PM. The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril. 1995;64(3):486-491.
Dubuisson JB, Chapron C, Ansquer Y, Vacher-Lavenu MC. Proximal tubal occlusion: is there an alternative to microsurgery? Hum Reprod. 1997;12(4):692-698.
Sueoka K, Asada H, Tsuchiya S, Kobayashi N, Kuroshima M, Yoshimura Y. Falloscopic tuboplasty for bilateral tubal occlusion. A novel infertility treatment as an alternative to in vitro fertilization? Hum Reprod. 1998;13(1):71-74.
Sato M, Yamada R, Kimura M, et al. Transvaginal fallopian tube catheterization–diagnostic and therapeutic usefulness. RadiatMed. 1993;11(2):49-52.
Strandell A, Bryman I, Janson PO, Thorburn J. Background factors and scoring systems in relation to pregnancy outcome after fertility surgery. Acta Obstet Gynecol Scand. 1995;74(4):281-287.
Wiedemann R, Sterzik K, Gombisch V, Stuckensen J, Montag M. Beyond recanalizing proximal tube occlusion: the argument for further diagnosis and classification. HumReprod.1996;11(5):986-991.
Woolcott R, Petchpud A, O’Donnell P, Stanger J. Differential impact on pregnancy rate of selective salpingography, tubal catheterization, and wire-guide recanalization in the treatment of proximal fallopian tube obstruction. HumReprod.1995;10(6):1423-1426.
Osada H, Kiyoshi Fujii T, Tsunoda I, Tsubata K, Satoh K, Palter SF. Outpatient evaluation and treatment of tubal obstruction with selective salpingography and balloon tuboplasty. Fertil Steril. 2000;73(5):1032-1036.
Sasse VV, Karageorgieva E, Keckstein J. Laparoscopic treatment of distal tubal occlusion-reocclusion and pregnancy rate. JAmAssocGynecolLaparosc.1994;1(4, Part 2):S32.
Letterie GS, Luetkehans T. Reproductive outcome after fallopian tube canalization and microsurgery for bipolar tubal occlusion. JGynecolSurg.1992;8(1):11-13.
Wurn LJ, Wurn BF, Kan M, King CR, Roscow AS, Scharf ES. Treating hydrosalpinx with manual physical therapy. Fertil Steril.2006;86 (Suppl 1): S307.
“Congratulations and thank you for providing a very effective and completely safe therapy that holds the promise for enhancing fertility and pelvic health for thousands of women worldwide.”
Miracle Babies by Gilli Moorhawk, Aphroditebooks, 2006:
“Blocked Tubes” The Wurn Technique® is a non-invasive bodywork therapy that uses manipulation techniques to help clear blockages and improve reproductive function. Many women who had blocked tubes or other unexplained infertility have conceived naturally following this treatment. The Wurn Technique® has been scientifically measured and published in medical journals.
“As an alternative approach that is in no way harmful, the procedure offers much hope for women whose medical history indicates possible adhesion or micro-adhesion formation or poor biomechanics, and women whose infertility is unexplained.”
What To Do When the Doctor Says It’s Endometriosis by Thomas Lyons, M.D., and Cheryl Kimball, Fair Winds Press, Glouceste,r MA, 2003:
(focusing on the Wurn Technique®, the authors refer to) “An alternative, nonsurgical soft tissue technique that has been effective in treating women with infertility problems.”
Stay Fertile Longer by Mary Kittel and Deborah Metzger, MD, PhD, published by Rodale Inc,. 2003
“Fertility Visionaries: Clear Passage® Therapies: Even health care practitioners who themselves had had no success with medical and surgical infertility treatments came, and had successful pregnancies.”
Do You Want to Have a Baby? Natural Fertility Solutions and Pregnancy Care by S. Abernathy and L. Page, PhD, published by Healthy Healing LLC, 2006:
“While long believed that surgical procedures were the only way to even partially decrease these problems [pelvic adhesions, blocked tubes, or other types of trauma or inflammation in the reproductive organs], bodywork therapists have found deep tissue work can not only decrease mechanical blockages, but also reduce pelvic pain and improve sexual arousal and orgasm for women. What a bonus!”
MAGAZINES
Woman’s World “Massage Made Me a Mom of Three!” by Andrea Florczak, March 6, 2007
(With her only fallopian tube totally blocked, and refused IVF due to hormonal factors) “Jennie Kennedy’s chances of ever having her own baby were zero…but [Clear Passage® Therapies] brought her not one, but three bundles of joy.”
Conceive “Rubbed the right way” by Lorie A. Parch, Spring, 2007
“Clear Passage® Therapies was developed as a method to repair pelvic adhesions that can prevent a woman from conceiving or carrying a pregnancy to term….To date, 167 babies have been born to mothers who received the treatment.”
Utne Reader, “Best Sex Ever: A Holistic Treatment Results in Really Hot Sex” by Laine Bergeson, April 2007
“The Wurn Technique®, which is an internal and external form of manual manipulation of the body’s soft tissue and fascia (connective tissue), aims to break up adhesions. This process, the Wurns believe, is what helps bring the pleasure back to sex.”
Psychology Today “Pressing Flesh” by Orli Van Mourik, December 2006
“Ninety-one percent of the participants in a recent peer-reviewed study of the (Wurn) technique experienced an overall improvement in sexual function; 56 percent reported an increase in the intensity and duration of orgasm.”
Achieving Families “Pelvic Physical Therapy for Infertility: a Physical Therapist Answers your Questions” by Belinda Wurn, PT, Sept/Oct, 2006″
The same adhesions that impair the proper function of the reproductive system can also affect a woman’s ability to become pregnant through IVF. Published studies show that certain manual physical therapies can significantly improve IVF success rates.”
Spa, “Fertile Ground” by Andrea Braslavsky, Jan/Feb, 2005:
“The Wurn Technique® applies soft tissue massage to the region between the navel and the knees to break down adhesions in the body’s connective tissue that can interfere with conception.”
Achieving Families, “Physical Therapy to Improve IVF Pregnancy Rates” by Amy Burnette, Sept. 2005:
“Researchers in the US recently studied a new manual physical therapy technique shown to be effective in improving IVF pregnancy rates. Women who received the therapy within 15 months prior to a fresh, non-donor IVF transfer had a 67% pregnancy rate…a significant increase over the 41% national average…for non-donor IVF transfers (without therapy).”
Health, “The Right Touch Boosts Fertility” by Julia VanTine Reichardt, December 2004:
“The [Wurn] technique, originally developed to treat musculoskeletal and postsurgical pain, may help reverse inflammation that can upset normal reproductive function.”
Infertility Times, “How One Woman’s Pelvic Pain Inspired a New Fertility Treatment” by Amy Burnette Hough, Nov./Dec. 2004:
“Clear Passage® Therapies® reports that at least 75 babies have already been born or are presently expected by previously infertile patients.”
Woman’s World, “Massage Made Me a Mom” by Nanette Reuckauf as told to Pat Wadsley, Aug. 6, 2002:
Woman’s World, “Massage Made Me a Mom” by Nanette Reuckauf as told to Pat Wadsley, Aug. 6, “After years of heartbreak [scar tissue on my fallopian tubes made me infertile], I’m finally a mom. Who would have thought all I needed was a [Clear Passage®] massage!”2002:
Massage & Bodywork, “Hands of Hope: Massage for Infertility” by Angie Best-Boss, April/May 2002:
“Clearly, the breakdown of adhesions through such non-invasive, less expensive means has its benefits, including restoration of fertility, decrease in pain, and an overall improvement in the quality of life.”
Advance, “PT for Infertility: A New Manual Therapy Technique Could be an Effective Treatment for Infertility” by Mike Le Postollec, March 2001:
“Preliminary results compiled by a professional researcher and former senior health policy advisor with the NIH indicated infertility reversal for a significant percentage of women who have received the treatment.”
“Get a massage. But not just any massage – try the Wurn Technique®”
Massage & Bodywork, “Soft Tissue Massage: Infertility Treatment of the New Millennium?” by Shirley Vanderbilt, Dec./Jan. 2000:
As a treatment for adhesions and tubal obstruction, the non-invasive approach of the Wurn Technique® is considered a safe and cost-effective therapy.”
Woman’s World, “Touched by a Miracle” by Amy Flurry, Sept. 14, 1999:
“I know I was skeptical at first about the therapy . . . But when I look at [my son] Tyler, I know it was the miracle I prayed for.”
Massage Magazine, “Manual Therapies May Help with Infertility”, March/April, 1999:
“Preliminary studies out of a physical therapy practice in Florida show promise that certain manual therapies may reverse a condition that causes infertility in women.”
Natural Health Magazine, “Massage Delivers Babies”, Dec. 1998:
Deep-tissue massage therapy [The Wurn Technique®] is showing promise as a treatment for some types of infertility. . . .Statistics show this effect is more than a coincidence.”
Jacksonville, “New Hope for Infertility”, Oct. 1998:
“There may be a less expensive, more effective non-surgical alternative for some infertile women, according to promising research being conducted at Clear Passage® Therapies, Inc.”
Women’s Digest, “Alternative Infertility Treatment Shows Promise”, July 1998:
“Researchers are investigating a new, non-surgical approach to treat female infertility. The investigators became interested when several women, diagnosed as infertile, became pregnant following therapy.”
TELEVISION
KRON-TV 4 San Francisco and Bay Area November 2006
The manual physical therapy (Wurn Technique®(R)) decreased pain throughout the menstrual cycle. Relief continued six weeks after therapy, according to an abstract published in “Fertility and Sterility” (9/2006). A related abstract in the same issue reported that the therapy significantly decreased dyspareunia (intercourse pain) and improved sexual function for women with endometriosis.
TXCN Texas Cable News, November 2006
The treatment is of interest because it decreased pain without the risks associated with surgery or pharmaceuticals. The therapy improved pregnancy rates for patients undergoing in vitro fertilization (IVF) and appeared to improve natural fertility rates.
FOX 35 News
“Infertility Update” by Reporter Elizabeth Alvarez, May 2006: “There is another option out there for women with issues like blocked fallopian tubes who feel like they have no choices except in vitro.”
CNN – NBC – CBS- ABC- Time-Warner Cable
National Broadcast, Jan. 2002: “Massages are used to help people relax. Now a particular type of massage [the Wurn Technique®] shows signs of having another benefit, as a fertility treatment.”
Fox Channel 7 News
“The Right Rub:” “Women from all over the world are coming to Clear Passage® for a new infertility treatment.”
WAMI-TV (Fox), National Broadcast, Feb. 25, 1999: “Even the fertility experts say this could increase the odds of having a child.”
ONLINE NEWS
Seattle Post-Intelligencer.com November 2006
Encouraging findings on a new treatment for endometriosis pain use a pelvic physical therapy that feels like a deep massage. The treatment is of interest because it decreased pain without the risks associated with surgery or pharmaceuticals.
Yahoo News, November 2006
Scientists at the Annual Meeting of the American Society for Reproductive Medicine (ASRM) reported that therapists were able to open totally blocked fallopian tubes using a new pelvic physical therapy that feels similar to a deep massage. Previously, surgery was the only treatment option for women with blocked fallopian tubes.
RedOrbit Breaking News November 2006
The manual physical therapy (Wurn Technique®(R)) decreased pain throughout the menstrual cycle. Relief continued six weeks after therapy, according to an abstract published in “Fertility and Sterility” (9/2006). In an earlier published study (“Medscape General Medicine,” 6/2004), the therapy improved pregnancy rates for patients undergoing in vitro fertilization (IVF) and appeared to improve natural fertility rates.
MedicalNewsService.com
MedicalNewsService.com
“In a recently published peer-reviewed study, (The Wurn Technique® ) relieved or eliminated intercourse pain in 96% of the women treated, and showed statistically significant improvements in all six major areas of sexual function.”
Apria Healthcare
Scientists at the Annual Meeting of the American Society for Reproductive Medicine (ASRM) reported that therapists were able to open totally blocked fallopian tubes using a new pelvic physical therapy (Wurn Technique® ) that feels similar to a deep massage. Previously, surgery was the only treatment option for women with blocked fallopian tubes. The Wurn Technique® opened blocked fallopian tubes in several women, some of whom conceived naturally after the therapy, according to the study abstract published in “Fertility and Sterility” (9/2006).
Orthopedic Technology Review
“Over 150 babies born or expected after non-surgical infertility treatment – peer-reviewed medical studies published. The new treatment is considered low risk as it uses no drugs or surgery. The therapy is used to treat infertility and pelvic and intercourse pain and is available exclusively at several Clear Passage® Therapies® clinics from New York to California.” June 2006
Forbes.com, “101 Babies Expected After New Infertility Treatment,” Oct. 2005:
“Over one hundred babies have been born or are expected by women diagnosed as infertile after receiving a new physical therapy treatment, similar to a deep massage.”
WebMD Medical News, “A Hands-On Approach for Infertility: Patented Massage Treatment Shows Promise in Difficult-to-Treat Cases” by Salynn Boyles, Oct. 23, 2002:
Stacy says, “When I started the treatment, they told me I might get pregnant, but I laughed. . . .Two months later, I was pregnant. I couldn’t believe it.”
www.conceivingconcepts.com, “New Infertility Treatment Shows Success Without Surgery or Drugs”, March 2002:
“Women [all diagnosed as infertile] became pregnant after they received a new therapy, without resorting to surgery or drugs, using a treatment that combines physical therapy with ‘site-specific’ massage.”
NEWSPAPERS
The Sioux Falls Argus Leader, “Alternative paths to pregnancy” by Monica LaBelle, March 21, 2007:
“Miranda credits the nondrug, nonsurgical treatment done by Clear Passage® Therapies® for the baby girl she’s expecting April 10.”
The Tampa Tribune (a NY Times publication), “At Long Last, Baby” by Karla Jackson, July 17, 2003:
“A Citrus Park couple with an infant daughter credits a massage technique for helping them end years of infertility.”
The Gainesville Sun (a NY Times publication), “Area Therapist Has Answer to Infertility” by Bob Arndorfer, 5/02:
“I did the ‘Wurn therapy’ which involved manipulation of the tubes and ovaries to put everything back in order,” Alex said. A few months later, a home pregnancy test turned out positive, and nine months later, a healthy 9-pounder named Henry was born.”
The Gainesville Sun (a NY Times publication), “Mother Credits Therapy with Daughter’s Birth” by Doris Chandler, May 10, 1998:
“[The couple] had tried various fertility treatments for about ten years. But then the unexpected happened. She became pregnant with Simone, which the couple attributes to physical therapy treatments at a Gainesville clinic.”
NEWSLETTERS
INCIID Insights, “Relief from Endometriosis Pain and Unexplained Infertility -Dana’s Story” by Jacqueline Schuld, April/May 2006:
Mom speaks after therapy: “It feels so wonderful being pregnant. I want other infertile women to know that they are not alone. That there is a chance.”
INCIID Insights, “Recurrent Miscarriage – My story” by Angela N. Richardson, Feb 2006:
“Who would have thought that the answers to my longings and prayers would lie in a natural, relaxing form of physical therapy. No needles, no pain, no drugs, no surgeries – just the healing power of human touch!”
INCIID Insights, “Blocked Fallopian Tubes, Endometriosis, Ovarian Cysts – Valerie’s Story” by Amy Burnette, January 2006:
“Clear Passage® is truly a blessing to couples like us, and we will be forever grateful [Valerie and Bill with baby Grace]. There was hope after all.”
GAINESVILLE, Fla., March 8, 2022 /PRNewswire/ — Blocked fallopian tubes are a major cause of female infertility, sending most women to surgery or in vitro fertilization (IVF). In a recent study, a treatment that feels like a deep massage opened blocked tubes in 61% of women, most of whom then conceived naturally. In a major study, the therapy (Clear Passage®) was shown to clear and often prevent bowel obstructions, which can be life-threatening.
“It started as a mistake,” says physical therapist Belinda Wurn. “We were treating a patient for pelvic pain due to internal scars called adhesions when she became pregnant. Then we learned she had been infertile for seven years due to blocked fallopian tubes. When the therapy worked on other infertile women, we decided to investigate.”
When a published study showed the therapy opened tubes in 143 women, people with recurring bowel obstructions asked if the therapists could open larger tubes: intestines blocked by adhesions. In a recent controlled study, the therapy did just that, potentially saving some from invasive surgery or death.
“Bowel obstruction is life-threatening and often requires emergency surgery,” says Stanford Professor of Surgery Janey Pratt, MD, a study author. “Since surgery is also a major cause of adhesions, obstructions can recur. It’s a big problem; surgery for intestinal obstruction is the second most common emergency surgery in the U.S.A. and carries a very high complication rate.” (JAMA Surgery, 2016)
Wurn developed the hands-on therapy with her husband, massage therapist Larry Wurn, when she experienced debilitating pain from post-surgical adhesions in 1984. When doctors told her no cure existed for adhesions, the couple felt they had no choice but to develop a treatment on their own. Over the ensuing decades, they found the therapy was useful for other conditions related to adhesions.
Over 1,000 babies have been born to patients diagnosed as infertile due to blocked tubes, endometriosis, and other causes. Some women have reported two or more full-term pregnancies after therapy. While most had natural pregnancies, the therapy has also been shown to be a useful adjunct to IVF when used before embryo transfer.
Safety and effectiveness of the therapy, which uses no drugs and no surgery, is supported by numerous peer-reviewed citations and studies published in medical journals available via PubMed and the National Library of Medicine. Available in the U.S.A. and in England, treatment is generally performed over five days, with two hours of hands-on therapy each morning and afternoon. Therapy applicants complete a Medical History Form, which Clear Passage® will review at no charge to determine appropriateness and likely success rates. For more information, call 352-336-1433, email info@clearpassage.com, or visit cp2.internetpresencetesting.com/.
Newscast: Medical infertility massage opens blocked fallopian tubes in an infertile woman; two subsequent pregnancies
University of Minnesota Medical School, Medical Degree
University of Florida, Clinical Associate Professor, Community Health and Family Medicine
University of Minnesota, Clinical Associate Professor, Department of Family Medicine
IntegraMed America, Vice President of Clinical Research
SmithKline Beecham Pharmaceuticals, Research & Development
Vice President, Director Worldwide Clinical Investigation
Biography, posts:
Marvin Heuer is an internationally recognized research physician with over 40 years of experience in the medical field and 25 years of experience in domestic and international clinical research. Graduating cum laude from Mankato State University in Minnesota in 1969, Dr. Heuer earned his medical degree from the University of Minnesota Medical School and completed his internship at St. John’s Hospital in St. Paul shortly thereafter. Dr. Heuer has been published in several peer-reviewed scientific publications and presented a wide variety of papers at research and medical conferences in the United States and abroad.
Dr. Heuer has served as the Vice President and Worldwide Director of Clinical Research for several companies, including SmithKline (now GSK), Wallace Laboratories (now Meda AB), and Ayerst Laboratories (now Pfizer). Moreover, He also served as the Chief Science Officer for Iovate Health Sciences International in the research and development of nutraceutical products. Dr. Heuer is a certified expert in FDA regulations and chemistry with extensive experience and interaction with the FDA, FTC, and ERSP within the pharmaceutical and nutraceutical industries. He actively continues practicing medicine, conducting clinical trials, and participating on review boards within the nutraceutical arena.
Dr. Heuer enjoys teaching, publishing, inventing, and actively serving within the community and professional societies. His contributions over the years have earned him numerous awards from the American Medical Association and the Marquis Who’s Who series.
Residency, Obstetrics and Gynecology: New York Presbyterian Hospital – Columbia Campus
Medical School: University of Miami Miller School of Medicine
Certifications & Licensure
American Board of Obstetrics and Gynecology, Certified in Obstetrics & Gynecology
NY State Medical License
Biography, posts:
Dr. Moritz is a board-certified OB/GYN with 30+ years of practice in New York City. He was the Director of Gynecology at Mount Sinai West for 25 years and is a renowned advocate for patient choice in childbirth. A testament to Dr. Moritz’s commitment to patient-centered women’s care, he created the only two operating in-hospital birthing centers in Manhattan. He lectures on new technologies in gynecological procedures, authored chapters on uterine fibroids, and has been listed in New York Magazine’s “Top Doctors” for the past five years.